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Abstract 
Objectives. To develop a remineralising dental composite with high strength, 
conversion and cytocompatibility and antimicrobial potential for more conservative 
treatment of dental caries. 
Methods. The effect of glass filler particle size distributions and glass fibres on wet-
point, handling and mechanical properties was assessed. The effect of two 
photoinitiators at varying concentrations and four co-initiators on conversion, 
cytocompatibility and mechanical properties was determined. The conversion, depth of 
cure, shrinkage, mechanical properties, water sorption and cytocompatibility of 
composites containing varying bulk (urethane dimethacrylate (UDMA), bisphenol A 
glycidyl methacrylate (Bis-GMA)) and diluent monomers (poly(propylene glycol) 
dimethacrylate (PPGDMA), tri(ethylene glycol) dimethacrylate (TEGDMA)) were 
characterised. The conversion, water sorption, calcium precipitation, mechanical 
properties and shear bond strength of composites containing remineralising and 
antimicrobial agents (monocalcium phosphate (MCP), tricalcium phosphate (TCP), ε-
poly-L-lysine (εPL)) were assessed (storage in water, simulated body fluid (SBF), 
artificial saliva (AS)). Techniques included Fourier transform infrared spectroscopy, 
mass and volume determination, biaxial flexural testing, shear bond testing, scanning 
electron microscopy, energy-dispersive X-ray spectroscopy, Raman spectroscopy, 
resazurin, WST-8 and MTS assays. 
Results. An optimal combination of fillers was established. Conversion was affected by 
co-initiator to a greater extent than photoinitiator. Composites containing UDMA and 
PPGDMA had the optimal balance of conversion, mechanical properties, depth of cure 
and cytocompatibility without increased shrinkage. Composites containing MCP with 
either TCP or εPL induced rapid hydroxyapatite formation on the surface of the 
composite within one week in SBF but not in AS or water. 
Significance. Composites containing the newly developed liquid phase had high 
conversion and strength, slightly improved cytocompatibility and acceptable shrinkage. 
Whilst composites containing MCP and TCP were stronger, the added possible 
antimicrobial action of those containing MCP and εPL have great potential to defend 
against recurrent caries by preventing microbial microleakage. 
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List of abbreviations 
3-MPTS 3-methacryloxypropyltrimethoxysilane, silane A174 
4-META 4-methacryloxyethyl trimellitate anhydride 
ACP amorphous calcium phosphate, CaxHy(PO4)z·nH2O (n = 3–4.5) 
ATR attenuated total reflectance 
β-TCP refer to TCP 
BFS biaxial flexural strength 
BHT butylated hydroxytoluene 
Bis-EMA bisphenol-A ethoxylate dimethacrylate 
Bis-GMA bisphenol-A glycidyl methacrylate 
BPA bisphenol-A 
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CQ camphorquinone 
D-value mass division diameter 
   - d10 diameter at which 10% of sample’s mass is comprised of smaller particles 
   - d50 mass median diameter 
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D-PBS Dulbecco’s phosphate buffered saline 
DCP dicalcium phosphate, CaHPO4 
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   - DCPD    - dicalcium phosphate dihydrate, also known as brushite, CaHPO4•2H2O 
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E Young’s modulus of elasticity 
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EDAB ethyl 4-(dimethylamino) benzoate 
EDX Energy dispersive X-ray spectroscopy 
εPL ε-poly-ʟ-lysine, (C6H12N2O)n (n = 23–33) 
FBS foetal bovine serum 
FRC fibre-reinforced composite 
FTIR Fourier transform infrared spectroscopy 
GF glass fibres, diameter 15 µm, length 300 µm 
GIC glass-ionomer cement 
GP0.7 glass particles, d50 = 0.7 µm 
GP5 glass particles, d50 = 5 µm 
GP7 glass particles, d50 = 7 µm 
GPa gigapascal 
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HA hydroxyapatite, Ca5(PO4)3(OH) 
HEMA 2-hydroxyethyl methacrylate 
HGF human gingival fibroblast 
LCU light curing unit 
LED light-emitting diode 
MCP monocalcium phosphate, Ca(H2PO4)2 
   - MCPM    - monocalcium phosphate monohydrate, Ca(H2PO4)2•H2O 
MPa megapascal 
Mr relative molecular mass 
MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium inner salt 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
η viscosity 
Mg-NTG-GMA N(p-tolyl)glycine-glycidyl methacrylate magnesium salt 
Na-NTG-GMA N(p-tolyl)glycine-glycidyl methacrylate sodium salt 
OX-50 fumed silica particles, d50 = 40 nm 
ρ density 
PAN polyacrylonitrile 
PLR powder to liquid ratio 
PMMA poly(methyl methacrylate) 
PPD 1-phenyl-1,2-propanedione 
PPGDMA poly(propylene glycol) dimethacrylate 
PMS phenozine methosulfate 
ppm parts per million 
P/S penicillin-streptomycin 
RI refractive index 
RMGIC resin-modified glass-ionomer cement 
TCP tricalcium phosphate, Ca3(PO4)2 
   - β-TCP    - β-tricalcium phosphate, Ca3(PO4)2 
TEGDMA tri(ethylene glycol) dimethacrylate 
Tg glass transition temperature 
TPO (Lucirin) 2,4,6-trimethylbenzoyl-diphenylphoshine oxide 
TRIS Tris(hydroxymethyl)aminomethane 
UDMA urethane dimethacrylate 
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UV-A near ultraviolet 
WOF work of fracture 
WST-8 sodium 5-(2,4-disulfophenyl)-2-(4-iodophenyl)-3-(4-nitrophenyl)-2H-
tetrazolium inner salt 
XTT 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide 
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1 INTRODUCTION 
This Chapter introduces dental anatomy, caries and restorative treatments. 
1.1 Dental anatomy 
1.1.1 Tooth organisation 
Teeth protrude from the maxilla (upper jaw) and mandible (lower jaw) into the oral 
cavity. Humans develop two sets of teeth during their lifetime and are consequently 
termed diphyodont. Deciduous (primary) teeth erupt from their location within the bone 
beneath the gingiva (gum tissue) approximately six months after birth. Permanent 
(adult) teeth typically begin erupting at the age of ~5–6 years, with mixed dentition 
present until this process is complete at the age of ~11–12. A full set of deciduous 
teeth consists of eight incisors, four canines and eight molars, from anterior to posterior 
(20 in total). A complete adult set consists of eight incisors, four canines, eight 
bicuspids (premolars) and 12 molars (32 in total)1. 
1.1.2 Tooth structure 
A tooth consists of four distinct tissue layers: enamel, dentine, cementum and pulp. 
The general structure of a tooth is illustrated in Figure 1.1. 
 
Figure 1.1. Dental anatomy. 
Cross-section of a molar. 
1.1.2.1 Enamel and cementum 
Enamel, the outermost layer, is a strong, hard and highly mineralised tissue consisting 
of ~96% hydroxyapatite (HA) and fluorapatite mineral phases and ~4% enamelin 
protein. It is only formed during tooth development, via the process of amelogenesis. 
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This involves the secretion of extracellular matrix (ECM) protein amelogenin by 
ameloblast cells. This protein is involved in initiation and organisation of mineral 
precipitation during tooth development. Enamel colour varies between individuals, from 
white, through greyish or slightly blue hues, to pale yellow. Due to its semi-
translucency, tooth colour is also influenced by the colour of the underlying dentine and 
any artificial restorations that extend beneath the enamel. Enamel is the only tissue 
exposed to the oral cavity in a healthy tooth and it varies in thickness, from a thin layer 
at the cementoenamel junction (CEJ) of ~300 µm2 (although this varies significantly 
from patient to patient3), up to ~2.5 mm thick at the cusp of the tooth. Enamel forms the 
occlusal (biting) surface of the tooth’s crown, up to the CEJ, to which the gingiva is 
attached. A glycoprotein film called pellicle is deposited by saliva on the surface of 
enamel, and acts as a barrier against over-mineralisation of enamel and against 
demineralisation via caries. Cementum, the outermost subgingival layer is a bone-like 
tissue which holds the root of the tooth in place below the CEJ and within the bone via 
the periodontal ligament. It is composed of ~45% HA, ~33% ECM and ~22% water and 
is subsequently softer than dentine1. 
1.1.2.2 Dentine 
Dentine forms the bulk of the tooth structure and consists of ~70% HA, ~10% water 
and ~20% ECM, most of which is fibrous collagen. It is served by parallel canaliculi, 
also known as dentinal tubules, which contain cytoplasmic extensions of odontoblasts, 
the cell bodies of which form the periphery between dentine and the underlying pulp 
layer. Odontoblasts lay down dentine via the process of dentinogenesis. During tooth 
development they form primary dentine. Secondary dentine is synthesised in 
developed teeth, whereas the formation of tertiary dentine is a defensive response to 
delay caries from reaching the pulp. The diameter of dentinal tubules progressively 
narrows from ~2.5 µm near pulp to ~0.9 µm near enamel. They maintain dentine 
quality by acting as a reservoir of ions, proteins and water, provided via the blood 
supply in the pulp and enabling the deposition of novel mineral1. 
1.1.2.3 Pulp 
Dental pulp is a highly vascularised tissue that resides within the pulpal chamber below 
dentine. The blood supply provides ions and nutrients for the maintenance of mineral 
and organic tooth components. It also contains nerves, which provide a sensory 
function in response to temperature, pressure and trauma, and which trigger tertiary 
dentine production by odontoblasts upon infection of the dentine. The cell body of 
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odontoblasts resides in the pulp, as does a supply of their multipotent precursors, 
dental pulp stem cells, which derive from mesenchymal stromal cells (MSC)1. 
1.2 Dental caries 
1.2.1 Aetiology 
Dental caries (tooth decay) is a disease characterised by pain and eventual loss of 
dental tissues, caused by bacterial infection. Microbes produce acids upon hydrolysis 
of nutrients, namely sugars that have accumulated within the pellicle, causing 
demineralisation of enamel, dentine and cementum. In a caries-free subject, the 
process of demineralisation occurs continuously. This is countered by remineralisation, 
induced by precipitation of calcium, phosphate and fluoride ions, which are present in 
saliva, fluoridated toothpastes and mouthwashes. Inside the tooth, ions are transported 
via passive mass transport from blood in the pulp via odontoblasts to the dentinal 
tubules where they form dentinal fluid, which supplies dentine with a source of ions. 
When oral pH drops below ~5.5, however, the equilibrium is disrupted and 
demineralisation exceeds remineralisation, resulting in net tissue loss. Erosion of the 
outer enamel layer is followed by bacterial infection and demineralisation of the 
underlying dentine. Caries can eventually reach the pulp, where it causes inflammation 
and pain. 
Caries is caused by an imbalance in the oral microbiome, which can be brought about 
by a high sugar diet and/or poor dental hygiene. Patients with genetic conditions in 
which proteins that guide tooth tissue formation or make up the ECM are mutated, 
such as amelogensis imperfecta and dentinogenesis imperfecta, are particularly 
susceptible to caries. These patients present extreme discolouration of the teeth, which 
are typically yellow, brown or grey due to the absence of enamel, and suffer from 
hypersensitivity. Caries can also be exacerbated by medical conditions which reduce 
the flow rate of saliva, such as Sjögren's syndrome, diabetes mellitus, diabetes 
insipidus, and sarcoidosis, as well as medications and recreational drugs that cause 
dry mouth. 
The most notable bacterial species responsible for dental caries are Streptococcus 
mutans and Staphylococcus aureus, with species from genera Lactobacillus, 
Bifidobacterium, Proprionibacterium and Actinomyces also reported to contribute. All of 
these bacteria stain Gram-positive and most are facultatively anaerobic. They utilise 
sugar and starch deposits on and around the teeth as a source of nutrients, most 
notably fermentable carbohydrates such as glucose, sucrose and fructose. Their 
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anaerobic respiration produces lactic acid as a by-product, which is responsible for the 
demineralisation of dental tissues and acts by dissolving the calcium and phosphates 
that form the bulk of the mineral. Large quantities of bacteria can build up and form a 
biofilm on the surface of and in-between teeth. This film is called plaque, and it can 
mineralise over time, forming tartar. Plaque creates an acidic environment on and 
around the teeth and can cause caries, gingivitis and/or periodontitis if not frequently 
removed via an oral hygiene regimen. Although saliva counters demineralisation, it is 
unable to penetrate the biofilm and neutralise the acids formed between the plaque 
and the tooth4. 
Formation of a cavity is irreversible. Although tertiary dentine can be laid down as a 
response to infection, the high mineral content makes the dentine and enamel 
inaccessible to stem cells and odontoblast protrusions that could otherwise potentially 
regenerate the organic phases of the tissues. Infection of the enamel causes 
demineralisation, which can eventually lead to infection of the dentine below, and in 
some cases, the pulp. Since dentine is a softer tissue than enamel, caries tends to 
progress at a more rapid rate once it has reached the dentine. The progression of 
caries is illustrated in Figure 1.2. 
 
Figure 1.2. Dental caries progression. 
Biofilm build-up (shown in dark brown) results in enamel demineralisation, followed by 
penetration of the dentine. This can eventually reach the pulp, causing inflammation and pain. 
1.2.2 Epidemiology 
Dental caries is amongst the world’s most prevalent diseases and is the most common 
childhood disease. Between 1999 and 2004, it affected 21% of American children aged 
2–11 with adult teeth, 59% of adolescents and 92% of adults and seniors, with around 
20% of the total population having had caries that had gone untreated. A significant 
decline in prevalence between the 1970s and 1999 may be attributed to improved 
dental hygiene. However, there is still great disparity between different ethnicities, 
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which is apparent between subpopulations in the USA, e.g. disparities between 
communities of Caucasian and Hispanic origin, and between populations with low vs. 
high income. Whilst genetic susceptibility may contribute to this variation, 
socioeconomic factors are the most significant cause of disparate rates of caries 
across the world5. 
1.2.3 Prophylaxis 
Oral hygiene and dietary modification are prophylactic methods used to prevent dental 
caries. Routine tooth brushing twice per day and regular use of dental floss prevents 
build-up of plaque and help to minimise tooth demineralisation caused by the microbes 
that constitute the biofilm. Since high sugar diets result in high levels of caries, sugar 
intake should be kept to a minimum, in particular with regards to drinks with high sugar 
content. A high calcium diet and calcium and fluoride supplements have been shown to 
decrease susceptibility to caries. Additionally, the widespread inclusion of fluoride in 
toothpastes and mouthwashes is highly beneficial to caries prevention6. 
1.2.4 Treatment 
Dental caries is typically treated by removing infected (and sometimes some affected) 
dental tissue and replacing the void using dental restorative materials, such as those 
discussed in Chapter 1.3. 
1.3 Dental restorative materials 
Humans have been making efforts to restore teeth since prehistoric times. The most 
ancient known dental filling, discovered in Slovenia, consists of beeswax and dates 
back to the 6,500 years to the Neolithic period (Figure 1.3)7. 
 
Figure 1.3. Earliest known example of a dental restoration. 
A Neolithic beeswax filling in a left canine found in Slovenia. Figure reproduced from Ref. 7 
under the terms of the Creative Commons Attribution License. 
Amalgam was developed in the 19th century and is still widely used today. There is, 
however, an increasing trend towards clinicians and patients favouring white, aesthetic 
fillings, including composites, glass-ionomer cements (GIC) resin-modified glass-
ionomer cements (RMGIC) and compomers. As demand increases, so too does the 
need to overcome the disadvantages of existing restorative materials. Chapter 1.3 
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provides a brief introduction to the composition and the advantages and disadvantages 
of each type of material. 
1.3.1 Amalgams 
Amalgams are malleable mercury alloys containing silver, tin, zinc and copper. 
Unfavourable due to their poor aesthetics and destructiveness to healthy tissue, 
researchers have sought to replace amalgams with more aesthetically suitable 
materials over the last fifty years. Despite significant advances, amalgam is still widely 
used, due to its durability, longevity and low cost. One major issue that modern 
materials overcome with relative success is that amalgam restorations often require 
removal of sound tooth structure in order to anchor the restoration to the tooth, since it 
does not bind to the tissue. Furthermore, amalgam expands and contracts in response 
to heat and cold much more rapidly than the tooth8, which can exert pressure on the 
remaining tooth structure. 
Mercury is a heavy metal which imparts an advantageous bacteriostatic effect on 
microbes, but is highly toxic at sufficient doses (acute effects observed at dose of 14–
57 mg/kg body weight for an adult9) and harmful to living organisms. The use of 
amalgam was phased out in Norway, Denmark and Sweden over the early 2000s and 
eventually banned in Scandinavia by 2009. The phasing out of amalgam is justified by 
two issues, with emphasis on the latter: mercury concentration in the liver is directly 
proportional to number of amalgam fillings and although levels of mercury leaching are 
low, its presence in the liver is of concern; manufacture and disposal of mercury-based 
materials results in environmental contamination of water sources and soil, which in 
turn are toxic to humans and other organisms in the food chain. 
Furthermore, the Minamata Convention on Mercury10 is an international treaty 
implemented by the United Nations Environment Programme to protect humans and 
the environment from mercury contamination. Signed by the UK in October 2013 and 
by a further 127 countries since, including the US and all EU member states, it aims to 
phase out the use of dental amalgam. Whilst it does not absolutely preclude the use of 
amalgam where its use would be beneficial to the patient, it seeks to encourage more 
conservative use of amalgam for the benefit of most patients and the environment. 
Composites are in most cases a more appropriate alternative to amalgam. 
1.3.2 Composites 
Composites were introduced in the early 1960s11 as an attempt to improve the 
aesthetics of fillings. They consist primarily of radiopaque glass particle filler bound 
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together by a network of synthetic polymers, most commonly dimethacrylates and 
more recently, ring-opening siloranes. Most current commercial composites are 
supplied premixed in syringes that do not require mixing by the clinician and are cured 
by photoinitiation using a light-curing unit (LCU). Composites have superior aesthetics 
and mechanical properties compared to other white dental restorative materials. They 
have excellent handling properties and depending on formulation, can be layered 
incrementally or used to bulk fill cavities. As with other aesthetic fillings, they allow 
minimal enamel and dentine removal and are significantly less destructive than 
amalgam. 
There are two major drawbacks, however, that affect composite longevity. The bond 
between the tooth and restoration has low durability, since it is based on a physical 
interaction between the polymer and the collagen fibres in dentine, which are exposed 
upon acid-etching (described in more detail in Chapter 2.2). Furthermore, upon curing, 
composites contract by ~2–6 vol% due to polymerisation shrinkage. These factors can 
cause debonding of the composite and in some cases eventually result in microbial 
microleakage between the tooth and restoration. Despite their high strength, 
composites are brittle and have a relatively high fracture and failure rate12-14. 
Dimethacrylate composites are described in more detail in Chapter 1.4. 
The general procedure for performing a composite restoration involves the removal of 
infected and sometimes some affected tissue, followed by etching (discussed in more 
detail in Chapter 2.2) and treating of the cavity. An adhesive is then applied and cured, 
followed by incremental layering and curing of the composite. The final layer is 
sculpted, cured and then polished. 
1.3.3 Glass ionomer cements 
Introduced in the early 1970s, GICs consist of silicate glass powders and organic 
acids. They are chemically cured and adhere to the tooth via an acid-base reaction, 
which forms a more durable chemical bond to the mineral than composite adhesives 
do to collagen. GICs release fluoride for a relatively long period and can act as a 
fluoride reservoir, “recharging” in the presence of fluorides in drinking water, 
toothpastes and mouthwashes. This can help to increase the level of fluorapatite in 
enamel and has a bacteriostatic and bactericidal effect. Fluorapatite is significantly less 
soluble than HA and addition of fluoride to tap water has successfully reduced the 
incidence of dental caries in a large number of case studies15. One major drawback of 
GICs is that they are considerably weaker than composites. As they are brittle, they are 
not favoured in load-bearing cavities. Whilst they have relatively good aesthetic 
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properties, they fail to match teeth as accurately as composites due to their lack of 
translucency. In addition, they have poor wear resistance and longevity16,17. 
1.3.4 Resin-modified glass ionomer cements 
RMGICs are hybrids of GICs and composites that contain a dual thermal initiator and 
photoinitiator curing system. They have aesthetic properties between those of GICs 
and composites. Their composition is similar to that of GIC, with the addition of 
monomers such as HEMA and photoinitiators. They also act as a fluoride reservoir. 
RMGICs have poor wear resistance and are stronger than GICs but weaker than 
composites, rendering them unsuitable for occlusal surfaces. Whilst they are 
cosmetically superior to GICs, they also fail to match the aesthetics of composites. 
1.3.5 Compomers 
Compomers (polyacid-modified composite resins) are GIC-composite hybrids with 
greater monomers content than RMGICs, resulting in greater strength. Their aesthetics 
are superior to RMGICs and GICs, but inferior to composites. They release a small 
quantity of fluoride, though this is thought to be clinically insignificant, and they do not 
act as a reservoir. Like composites, compomers require use of a bonding agent14,16,18. 
1.3.6 Advantages and disadvantages of restorative materials 
The advantages and disadvantages of the aforementioned dental restorative materials 
are summarised in  
Table 1.1. Advantages and disadvantages 
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. This is an approximation based on the literature and discussions with clinicians, 
including Dr. Paul Ashley (Paediatric Dentistry, UCL Eastman Dental Institute). 
Aesthetics are increasingly considered to be one of the most important factors 
concerning dental restorative materials. 
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Aesthetics      
Minimally invasive      
Restoration longevity      
Strength      
Application in load-bearing teeth      
Bond or retention durability      
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Wear resistance      
Lack of shrinkage and bacterial microleakage      
Contains potentially bacteriostatic components      
Minimal toxic potential (patients/clinicians)      
Minimal toxic potential (environment)      
Handling properties and working time      
Affordability      
Excellent        Very poor 
1.4 Aims and objectives 
The aim of this project was to develop a novel remineralising dental composite with 
high strength, improved cytocompatibility and antimicrobial potential for more 
conservative treatment of dental caries. Such materials have the potential to protect 
against dental caries whilst allowing minimal removal of healthy tissue19. The 
hypotheses and objectives are summarised sequentially below and are discussed in 
greater detail in the corresponding chapters. 
• The use of long, flexible monomers with high relative molecular mass (Mr) and low 
double bond concentration should result in high conversion (≥ 70%) compared to 
many commercial composites (~50%). This in turn should improve mechanical 
properties and cytocompatibility without detrimentally affecting shrinkage or 
aesthetics. 
• The use of calcium phosphates (CaP) should result in water sorption, followed by 
CaP release and the precipitation of stable mineral on the composite surface. The 
water sorption and remineralisation together have the potential to seal the interface 
between the tooth and restoration, preventing microbial microleakage, recurrent 
caries and restoration failure. This could enable the removal of less of the healthy 
tissue, making the procedure less invasive and painful. This could be of particular 
benefit to paediatric patients and patients in developing countries, where access to 
costly dental equipment such as drills may be restricted. 
• The use of a highly soluble preservative has the potential to aid CaP release and 
nucleation, as well as protect against microleakage through its antimicrobial action. 
• The use of reinforcing fibres should improve the toughness and therefore longevity 
of the composite, making it ideal for load-bearing restorations. 
• The aesthetics of the cured composite must remain of acceptable quality. 
The material under development aims to overcome some of the shortcomings of 
existing composites whilst introducing additional novel features that could contribute to 
a new generation of multi-action restorative materials. These materials could 
particularly benefit young and disadvantaged patients, who can be more difficult to 
 29 
 
 
treat due to anxiety20 and lower access to affordable dental care. They also trigger a 
shift to “smarter” dental materials which continue to function and “respond” to the 
clinical situation after application, an approach which is targeted in other biomaterials 
and drug delivery approaches, e.g. in this case through recurrent caries causing further 
release of remineralising and antimicrobial agents.  
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2 COMPOSITES 
This chapter describes the composition of dimethacrylate-based composites in greater 
detail, introducing the mechanism of polymerisation and adhesion and discussing their 
typical composition. It also describes innovative variations of composites, such as 
remineralising, antimicrobial and fibre reinforced materials. 
2.1 Dimethacrylate polymerisation 
The most widely used type of monomer used in dental composites is dimethacrylates, 
which are linear molecules containing a methacrylate group (CH2C(CH3)C(OH)OR–) at 
each end that were developed by Bowen in the early 1960s11. Although other types of 
monomers have been developed with the aim of reducing shrinkage, such as ring-
opening siloranes, these are beyond the scope of this thesis. The polymerisation 
discussed therefore refers to that of chain growth polymerisation of dimethacrylates. 
Chain growth polymerisation can be described to occur in three phases, preceded by 
the formation of free radicals (Figure 2.1). Radicals are formed either via thermal 
initiation or photoinitiation. The majority of dimethacrylate-based composites are 
initiated by photoinitiation (discussed in more detail in Chapter 2.3.1), whereas 
orthopaedic cements are typically initiated via a thermal reaction, which occurs upon 
contact between an initiator and co-initiator. 
 
Figure 2.1. Chain growth polymerisation. 
Initiation, propagation and termination reactions of chain growth polymerisation in a simple 
methacrylate system. 
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The free radicals generated during photoinitiation in turn initiate the polymerisation 
process. A new C–C bond is formed between a radical and a methacrylate group 
belonging to a monomer molecule. This occurs when the radical and the alkene group 
(C=C) of the methacrylate group each donate an electron. Another electron from the 
alkene group relocates to the C at the opposite terminus of the monomer. The resulting 
molecule still has an extra electron, meaning it then acts as a radical and reacts with 
another monomer molecule. This process occurs numerous times and results in chain 
growth of the polymer. The process is terminated when two radicals react with one 
another. Any free radicals that may remain after the polymer has formed may either 
recombine or eventually diffuse out of the polymer. 
The situation in a dental composite containing multiple monomers of high Mr is more 
complicated than the example illustrated in Figure 2.1. Since the monomers are 
dimethacrylates, the resulting polymer is highly cross-linked. Cross-linking improves 
mechanical properties, wear resistance and cytocompatibility but increases shrinkage. 
2.2 Composite adhesion 
Since GICs and RMGICs are able to bond chemically to the tooth structure via an acid-
base reaction, they do not require an adhesive agent. They also have a lower failure 
rate than composites and compomers, which require conditioners, primers and 
adhesives. The adhesive interacts with the tooth via a weaker, micro-mechanical bond 
rather than covalent bonding. A conditioner removes the bacterial “smear layer” and 
etches the tooth. It consists of an acidic gel, such as 37% phosphoric acid, or acidic 
monomers. Primers consist of bifunctional monomers such as 2-hydroxyethyl 
methacrylate (HEMA), a surfactant which is hydrophilic at one end and hydrophobic at 
the other. HEMA is able to bind to both the composite and collagen and expand the 
matrix. Primers do not contain fillers and in order to reduce their viscosity and improve 
wetting of the etched tissue, they contain volatile solvents such as ethanol, which 
evaporate after application. Adhesives contain adhesive monomers, which create a 
durable bond that links the primer to the composite. They seal the dentine tubules and 
form a “hybrid layer” between the demineralised dentine and the restoration. As a 
general rule, preparation of the tooth with more steps results in a more reliable bond 
(Table 2.1)21. 
In enamel, the conditioner etches gaps around the apatite crystals, allowing the primer 
to envelop the crystals. In dentine, it demineralises peritubular and intertubular dentine 
(dentine along the lining of the tubules and between tubules, respectively), exposing 
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~5–8 μm of collagen matrix, around which primer binds (Figure 2.2). The branched 
structures created by resin around the tubules are called tags. The more branched the 
tag, the more durable the bond (Figure 2.3)21-26. 
 
Figure 2.2. Demineralised dentine. 
The etched dentine layer consists of ECM components and lacks mineral. The composite 
binds around the exposed collagen, forming a mechanical bond to the tooth. Reproduced with 
permission from Ref. 27, © Elsevier Ltd. 
 
 
Figure 2.3. Resin tag hybridisation. 
(a) Poorly and (b) well hybridised resin tags. Reproduced with permission from Ref. 27, © Wiley 
Periodicals Inc. 
 
  
Table 2.1. Tooth preparation techniques and annual failure rates. 
Technique Mean annual failure rate (%) Preparatory steps 
3-step etch & rinse 4.8 ± 4.2 1. Etch & rinse            2.Primer            3. Adhesive 
2-step etch & rinse 6.2 ± 5.5 1. Etch & rinse            2. Combined primer & adhesive 
2-step self-etch 4.7 ± 5.0 1. Acidic monomer primer                    2. Adhesive 
1-step self-etch 8.1 ± 11.3 1. Combined acidic monomer primer & adhesive 
GIC 1.9 ± 1.8 None 
From Ref. 22. 
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2.3 Composite components 
This section introduces the components used in the present research. In some cases, 
examples of other commonly used components are briefly described. The information 
in the tables is provided by the corresponding manufacturer. 
2.3.1 Liquid phase 
The liquid phase of a typical dental composite consists of monomers combined with a 
photoinitiator system. These compounds are also widely used in dental adhesives and 
have been comprehensively reviewed25. In Chapter 2.3.1, the liquid phase components 
used throughout the present research are listed and some of their relevant 
characteristics are introduced. 
2.3.1.1 Bulk monomers 
Bulk monomers are the main constituent of the liquid phase. They tend to have high 
viscosity (η), typically due to chemical groups that hinder flexibility. This tends to result 
in stronger, more rigid materials upon curing. The bulky aromatic groups of commonly 
used monomer bisphenol-A glycidyl methacrylate (Bis-GMA, Figure 2.4b), for example, 
hinder mobility and create stiff composites28. In addition, hydroxyl groups cause 
intermolecular binding between molecules, e.g. via hydrogen bonds. The very high 
viscosity (~700 Pa·s) that results from this, however, impedes diffusion of the reactive 
species formed during the polymerisation reaction, preventing even propagation of the 
polymer throughout the full depth of the material as the reaction progresses and 
resulting in low conversion and depth of cure (DC). In contrast, bisphenol-A ethoxylate 
dimethacrylate (Bis-EMA, Figure 2.4a) lacks hydroxyl groups and is more flexible and 
much less viscous (~3 Pa·s) as a result. Similarly, urethane dimethacrylate (UDMA, 
Figure 2.4c) is much less viscous than Bis-GMA (~8.5 Pa·s). Its viscosity remains high 
enough to create a packable material that is easy for clinicians to sculpt into shape, yet 
sufficiently low to achieve a high PLR, since the viscosity of the liquid phase affects the 
level of wetting of the fillers. 
Commercial composites typically contain a mixture of bulk monomers, the ratio of 
which is not normally disclosed. Filtek Z250 (3M ESPE), for example, contains Bis-
GMA, UDMA and bisphenol-A ethoxylate dimethacrylate (Bis-EMA) together with 
diluent monomer tri(ethylene glycol) dimethacrylate (TEGDMA). 
Rigidity of monomers is inherently associated with brittleness. The complete 
replacement of Bis-GMA with UDMA as the bulk monomer may result in composites 
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with lower water sorption29, lower modulus and improved toughness30 without 
significantly higher shrinkage31. 
Furthermore, Bis-GMA has historically been synthesised from a bisphenol-A (BPA) 
precursor, which has been proved to be oestrogenic (oestrogen mimicking), which is of 
concern to patients, particularly children who are still developing32. Although many 
manufacturers now synthesise BPA-free Bis-GMA via a different route, hydrolysis of 
Bis-GMA may still result in low levels of BPA leaching from composites. 
For these reasons, the total replacement of Bis-GMA with UDMA is investigated in 
Chapter 5. The chemical structures of Bis-EMA, Bis-GMA and UDMA are illustrated in 
Figure 2.4 and their physical properties are presented in Table 2.2. 
 
Figure 2.4. Chemical structures of bulk monomers. 
(a) Bisphenol-A ethoxylate dimethacrylate (Bis-EMA), (b) bisphenol-A glycidyl 
methacrylate (Bis-GMA) and (c) urethane dimethacrylate (UDMA). 
 
 
 
 
 
 
 
 
 
 
2.3.1.2 Diluent monomers 
Diluent monomers are incorporated alongside bulk monomers in composite liquid 
phases in order to reduce viscosity. The ratio of bulk to diluent monomer is typically 
such that the diluent monomer constitutes around one third or less of the liquid phase. 
This is in order to maintain optimal physical properties, such as high strength and low 
shrinkage. 
Table 2.2. Bulk monomer physical properties 
Bulk monomer Mr ρ (g/cm3) RI η (Pa·s) 
Bis-EMA 540 1.12 1.49–1.53 3 
Bis-GMA 512 1.16 1.54 700 
UDMA 470 1.12 1.48 8.5 
(a) 
(c) 
(b) 
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TEGDMA (Figure 2.5b) is the most widely used diluent monomer. Its very low viscosity 
(~0.09 Pa·s) means that only a small proportion must be used in order to improve the 
flow and handling properties of the composite. TEGDMA, however, has poor cyto- and 
genocompatibility33-37, acts as a vasorelaxant38-42 and causes apoptosis and 
necrosis43,44. Furthermore, its high double bond concentration increases shrinkage. Its 
omission from composites would therefore be ideal. The use of poly(propylene glycol) 
dimethacrylate (PPGDMA, Figure 2.5a) in place of TEGDMA was therefore 
investigated in Chapter 5. The use of PPGDMA, which is a larger molecule with 
significantly lower double bond concentration than TEGDMA, has not previously been 
investigated in dental composites. 
The chemical structures of PPGDMA and TEGDMA are illustrated in Figure 2.5 and 
their physical properties are presented in Figure 2.5. 
 
Figure 2.5. Chemical structures of diluent monomers. 
(a) Poly(propylene glycol) dimethacrylate (PPGDMA) and (b) triethylene glycol dimethacrylate 
(TEGDMA). 
 
 
 
 
 
 
 
 
 
2.3.1.3 Photoinitiators 
Di-2,3-diketo-1,7,7-trimethylnorcamphane, a yellow powder more commonly known as 
D,L-camphorquinone (CQ, Figure 2.6a & Table 2.4) is historically the most commonly 
used photoinitiator in dental composites and adhesives and is used in combination with 
a co-initiator. It is a type II (electron-transfer) photoinitiator which, upon exposure to 
blue visible light, interacts with a co-initiator (an electron donor) such as a tertiary 
amine, yielding radicals by hydrogen abstraction25. Each α-dicarbonyl CQ molecule 
becomes a ketyl radical and each co-initiator molecule becomes an amino alkyl radical. 
This process is illustrated in Figure 2.7. CQ is well characterised and its use is 
advantageous, due to its broad absorbance range of 360–510 nm, with peak 
absorbance in the visible blue light spectrum at 468 nm. Dissolution in monomers such 
as TEGDMA results in a bathochromic shift (lengthening of the peak absorbance 
Table 2.3. Physical properties of diluent monomers. 
Diluent monomer Mr ρ (g/cm3) RI η (Pa·s) 
PPGDMA 600 1.01 1.45 0.09 
TEGDMA 286 1.09 1.46 0.05 
(a) (b) 
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wavelength) to 474 nm. These wavelengths are covered by LCUs, which are currently 
the most commonly used light sources and utilise blue light-emitting diodes (LED) with 
a wavelength range of approximately 400–500 nm45. The main disadvantage of CQ is 
its colour. Depending on the output power and wavelength, this yellowness is bleached 
by some LED units more efficiently than by others46. Furthermore, CQ has been shown 
to significantly alter metabolism of several structural lipids in vitro, which may affect 
membrane integrity and permeability47. A low CQ concentration or replacement with an 
alternative photoinitiator may therefore be desirable. 
 
Figure 2.6. Chemical structures of photoinitiators. 
(a) Di-2,3-diketo-1,7,7-trimethylnorcamphane (D,L-camphorquinone, CQ), (b) 2,4,6-
trimethylbenzoyl-diphenylphosphine oxide (TPO) and (c) 1-phenyl-1,2 propanedione (PPD). 
 
 
 
 
 
 
Another class of photoinitiators called acylphosphine oxides, of which 2,4,6-
trimethylbenzoyl-diphenylphosphine oxide (TPO, commercial name Lucirin, Figure 2.6b 
& Table 2.4) is an example, have strong absorption in the near ultra-violet (UV-A) 
spectrum, with some overlap of the visible blue light spectrum25,48. Such molecules are 
classed as type I (photo-fragmentation) photoinitiators and do not require a co-initiator. 
Each molecule is cleaved upon irradiation, forming two free radicals. This process is 
illustrated in Figure 2.8. Some composite manufacturers favour TPO for its less yellow, 
more off-white colour. When used at high concentrations, however, TPO turns yellow 
upon polymerisation49. TPO requires the use of a quartz tungsten-halogen light source. 
Since LED LCUs are currently more common and convenient than tungsten-halogen 
LCUs due to their more compact size, however, TPO was not utilised in the present 
work. 
Table 2.4. Physical properties of photoinitiators. 
Photoinitiator Mr ρ (g/cm3) RI Absorbance (nm) Range Peak 
CQ 166 0.97 * 360–510 474 
TPO 348 1.12 1.48 230–430 385 
PPD 148 1.10 1.53 300–480 410 
* Unknown      
(a) (c) (b) 
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Figure 2.7. Type II photoinitiation by hydrogen abstraction. 
 
 
Figure 2.8. Type I photoinitiation by photo-fragmentation. 
1-phenyl-1,2 propanedione (PPD, Figure 2.6c & Table 2.4) is an α-diketone which has 
the favourable property of being able to form free radicals by both type I and type II 
reactions. It absorbs light with a wavelength of 300–480 nm, with its peak on the edge 
of the visible light spectrum at 410 nm. PPD is a pale yellow liquid. It has been reported 
to result in increased mechanical strength and comparable or improved degree of 
conversion (DC) compared to CQ25. The free radicals formed by PPD are less likely to 
recombine than the two carbonyl radicals of CQ, which are structurally bonded to one 
another50, meaning their action may be prolonged compared to CQ. By contrast, 
however, presence of co-initiators reduces the rate of free radical development 
compared to CQ. Nevertheless, it has been reported that when PPD and CQ are 
combined at a ratio of between 1:1 and 1:4, respectively, they act synergistically to 
improve depth of cure51. 
Since the absorbance range of PPD overlaps that of the conventional LED units used 
to initiate CQ, they were used in conjunction with one another in Chapter 6, in order to 
investigate whether any improvement to mechanical properties and DC resulted from 
using both together. CQ was used alone in the remaining studies. 
2.3.1.4 Co-initiators 
Various tertiary amines are used in conjunction with type II photoinitiators such as CQ 
and PPD, for their ability to donate protons to the excited initiator molecules and form 
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free radicals. Tertiary amines consist of a nitrogen atom surrounded by three side 
chains (designated ‘R groups’, Figure 2.9a), which can vary in size and complexity. 
N,N-dimethyl-p-toluidine (DMPT, Figure 2.9c & Table 2.4) is historically one of the most 
commonly used co-initiators, though its use has declined due to realisation of toxic 
effects, caused by its low relative molecular mass (Mr 135) enabling it to readily 
penetrate cells and by its carcinogenic metabolites52. 2-(N,N-dimethylamino)ethyl 
methacrylate (DMAEMA, Figure 2.9b & Table 2.4) and ethyl 4-(dimethylamino) 
benzoate (EDAB, Figure 2.9d & Table 2.4) are commonly used co-initiators with slightly 
higher Mr than DMPT (193.2 and 157.2, respectively). DMAEMA has the advantage of 
containing polymerisable methacrylate groups, which allows it to become incorporated 
into the polymer during conversion, thus reducing the risk of leaching. 
Similarly, N(p-tolyl)glycine-glycidyl methacrylate (NTG-GMA, Figure 2.9e–f & Table 2.4) 
is polymerisable, but has the extra advantage of being trifunctional (it contains 
methacrylate, amine and salt groups). It can be obtained as either a magnesium or 
sodium salt. It is used in some dental adhesives for its ability to bind to positively 
charged groups such as the calcium ions that constitute tooth mineral, as well as to the 
polymer. Being a tertiary amine, it is also able to function as a co-initiator25. In the 
present research, NTG-GMA was compared to DMAEMA, DMPT and EDAB in order to 
determine whether its significantly higher Mr (329.2) helps to improve cytocompatibility. 
 
Figure 2.9. Chemical structure of co-initiators. 
(a) General chemical structure of a tertiary amine. Chemical structures of co-initiators (b) 2-
(N,N-dimethylamino)ethyl methacrylate (DMAEMA), (c) N,N-dimethyl-p-toluidine (DMPT), (d) 
ethyl 4-(dimethylamino) benzoate (EDAB) and (e) N(p-tolyl)glycine-glycidyl methacrylate sodium 
salt (Na-NTG-GMA). 
 
 
 
 
 
 
 
 
 
 
 
Table 2.5. Physical properties of co-initiators. 
Co-initiator Mr ρ (g/cm3) RI 
DMAEMA 157 0.93 1.44 
DMPT 135 0.94 1.54 
EDAB 193 1.06 1.53 
Na-NTG-GMA 329 * * 
* Unknown    
(a) (c) 
(b) (d) 
(e) 
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2.3.1.5 Inhibitors 
Inhibitors are incorporated into composites in order to prolong shelf-life, by preventing 
monomers from partially polymerising during storage. Monomer components tend to be 
supplied with low concentrations of inhibitor (typically ~30–250 ppm) but incorporation 
of additional inhibitor within the liquid phase helps to further prolong longevity of the 
material. Butylated hydroxytoluene (BHT, Figure 2.10 & Table 2.4) was used in the 
present work. BHT is analogous to vitamin E and prevents autoxidation by donating a 
hydrogen atom to convert peroxy radicals to hydroperoxides53. Monomethyl ether 
hydroquinone (MeHQ) is another commonly used inhibitor which was incorporated in 
some of the monomers by the suppliers (Table 3.1). 
 
Figure 2.10. Chemical structure of inhibitor butylated hydroxytoluene (BHT). 
 
 
 
 
 
2.3.2 Filler phase 
Dental composites may be classified in terms of their handling, a property which is 
affected by the powder to liquid ratio (PLR) and the composition of the filler phase. 
Flowable composites, for example, contain compounds such as HEMA in their liquid 
phase, which reduce viscosity without requiring a large reduction in filler content. This 
enables them to be dispensed from fine bore syringes and to flow into poorly 
accessible cavities. The downside of flowable composites is their relatively high 
polymerisation shrinkage of ~2–6 vol%, compared to ~2–4 vol% for universal 
composites, which are suitable for both anterior and posterior applications54. Packable 
composites are highly viscous pastes which often contain a more complex distribution 
of filler particle sizes in order to achieve more efficient filler loading. These materials 
are significantly stronger and can be easily sculpted by the clinician in order to create 
an aesthetic restoration. 
Radiopaque glass particles are used as the primary (bulk) filler component in dental 
composites. The primary roles of glass fillers are their aesthetics and strength. The 
radiopacity helps to identify the composites in X-ray radiographs. In the more 
Table 2.6. Physical properties of inhibitor. 
Inhibitor Mr ρ (g/cm3) RI 
BHT 220 1.04 1.49 
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innovative composites being developed in the present research, additional reactive 
components are incorporated into the filler phase in order to achieve mineral formation 
and antimicrobial protection. These are discussed in detail in Chapter 7. 
2.3.2.1.1 Bulk filler 
Silane-treated glass particles are the most common filler in composites, typically 
constituting the entire filler phase. It is only in more advanced remineralising, 
antimicrobial or reinforced composites that fillers with special functionality are usually 
added. Silane acts as a coupling agent in order to improve the bond between filler and 
polymer. Si binds covalently to the polymer, whilst O binds to the inorganic filler, as 
illustrated in Figure 2.11b55. 
Dental composites have in many previous studies been classified in terms of their filler 
size. The first generation of dental ‘macrofill’ composites contained particles in the 
broad range of 10–50 µm. These had high strength but were difficult to polish and 
suffered from wear, which negatively affected aesthetics. Following this, ‘microfill’ 
composites were developed. This name is somewhat misleading, since the amorphous 
fumed silica particles used (~40 nm on average) were on what is now regarded as the 
nanoscale. Due to its significantly larger specific surface area (50 ± 15 m2/g) of fumed 
silica compared to micro- and macroscopic glass particles, a low PLR was achieved. In 
order to overcome this, some materials incorporated highly filled, prepolymerised resin 
filler particles in combination with fumed silica particles. The small filler size of microfill 
composites improved the polishing and wear but the low filler content weakened 
them54. 
 
Figure 2.11. Glass filler types and silane coupling. 
(a) Chronological development of dental composite filler phases and (b) schematic 
representation of silane coupling between polymer and filler particles. Reproduced with 
permission from Refs. 54,55, © Elsevier Ltd. 
(a) (b) 
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Several categories of small particle hybrids were subsequently developed in order to 
create an optimal compromise between mechanical and aesthetic properties. ‘Midifills’ 
contained glass with an average particle size of just over 1 µm, in combination with a 
portion of fumed silica. Refinements in particle milling techniques later enabled 
development of ‘minifills’, with 0.4–1 µm particles combined with fumed silica. These 
later became known as ‘microhybrids’, most of which are universal composites with 
high strength, low wear and good polishing characteristic that can subsequently be 
used for both posterior and anterior restorations. More recently, the concept of 
microfills has been revisited, with ‘nanofill’ composites containing primarily 5-100 nm 
particles and ‘nanohybrids’ containing prepolymerised nanofillers. Nanohybrids are 
often indistinguishable from microhybrids in terms of composition30,54,56-58, although 
microhybrids tend to achieve slightly higher strength and modulus. The terminology 
and chronological development of dental composite filler phases is illustrated in Figure 
2.11a54. 
The incorporation of fumed silica particles into the filler phase allows for significantly 
more efficient loading, since the nanofillers occupy the space between the larger 
particles. Nanofillers form a much smoother surface when polished than larger particles 
and wear better. This is because large pores do not form when a particle is removed 
from the surface by wear. Smaller particles may result in increased light transmittance 
due to lower scattering of light59 and therefore improve conversion and depth of 
cure30,56. 
Fumed silica has been used in a wide range of applications for many years, including 
in dental composites and as a light abrasive agent in toothpastes. When a hydrophilic 
fumed silica such as OX-50 is incorporated into a nonpolar solvent such as a dental 
composite liquid phase, it exhibits thixotropic and rheopectic (shear-thinning and 
thickening) behaviour. The hydrophobic monomers are unable to adsorb on to the 
hydrophilic surface of the silica and as a result, the particles form aggregates. The 
aggregates then form agglomerates, which form in order to minimise the amount of 
free surface energy. The network of agglomerated particles that forms throughout the 
paste exhibits viscoelasticity (time-dependent creep) which is overcome upon 
application of shear forces, such as those caused by shrinkage stress. The non-bound 
silica agglomerates break apart and lead to an apparent reduction in viscosity, an 
effect that is reversed upon reduction of shear stress. This allows for thorough mixing 
of the paste at high PLR during manufacture and facile sculpting of the composite by 
the clinician. The fumed silica network also inhibits sedimentation of particles (including 
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other, larger fillers) and maintains homogeneity of the paste, which is important for 
preventing phase separation and improving shelf-life. 
In the present work, silane-treated boroaluminosilicate glass particles (Table 3.3) with 
d50 (median particle size) of 0.7, 5 or 7 µm were utilised. In the present thesis, these 
are termed GP0.7, GP5 and GP7, respectively. High purity fumed silicon dioxide particles 
(Table 3.3) with a mean particle size of ~40 nm was also incorporated into some 
experimental formulations at 10 wt% of the filler phase, in order to increase filler 
loading and improve handling properties. This is termed OX-50, based on its 
commercial name. 
2.3.2.1.2 Reinforcing glass fibres 
Various fibrous materials including glasses and polymers have been incorporated into 
dental composites as reinforcing agents. Such materials are known as fibre-reinforced 
composites (FRC). Long glass fibres are also used as prosthodontic bridges to fix an 
artificial tooth to adjacent teeth. 
For example, high aspect ratio HA nanofibres with an average diameter of 0.1 µm and 
length of 60–80 µm have been shown to increase flexural strength (FS) of composites 
by ~22% when incorporated at 10 wt%60. Similarly, electrospun polycaprolactam (nylon 
6) fibres with a diameter of 0.1–0.6 µm, for example, have been shown to increase 
composite FS by 36% and work of fracture (WOF, a similar concept to fracture 
toughness) by ~42% when incorporated at 5 wt%58. 
More complex FRCs have also been investigated61. These materials contain fibres with 
a polyacrylonitrile (PAN) core surrounded by a poly(methyl methacrylate) (PMMA) 
shell, formed by electrospinning. The outer shell of these nanofibres partially dissolves 
in the composite liquid phase, allowing semi-impregnation of the PMMA by the matrix 
at the interface (Figure 2.12). When incorporated at 7.5 wt%, 0.2–0.5 µm diameter 
nanofibres increased FS and WOF by ~19% and 65%, respectively. When fibres were 
aligned and elongated using a post-drawing technique, composites containing as little 
as 1.2 wt% fibres had ~52% and 152% higher FS and WOF, respectively. Nonetheless, 
the major drawback of electrospun polymers is their nonwoven fabric form, which must 
be applied in situ and be impregnated with the matrix. This restricts their use in dental 
restorations, a process that is performed under strict time constraints. Despite their 
impressive improvements to FS and WOF, such materials may be more appropriate for 
prosthodontic applications. 
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Figure 2.12. PAN core PMMA shell nanofibres. 
Schematic of (a) general structure, (b) interaction between PMMA shell and dental resin, (c) 
semi-interpenetrating polymer network and (d) chain entanglement at the PMMA-resin interface. 
Reproduced with permission from Ref. 61, © Elsevier Ltd. 
An off-the-shelf FRC called everX Posterior is also commercially available (StickTech, 
Finland, distributed via GC, Japan). This composite contains E-glass (alumino-
borosilicate containing < 1 wt% alkali oxides) fibres, similar to those used in other 
StickTech products such as bridge reinforcements but up to 3 mm in length, compared 
to several cm for bridges. Experimental work performed by the laboratory that 
developed everX Posterior has demonstrated that E-glass fibres improve FS and 
fracture toughness and reduce creep and shrinkage62-64. 
2.3.2.1.3 Remineralising agents 
Over the past century, various different calcium phosphate (CaP) phases have been 
incorporated into a diverse range of dental and orthopaedic restorative materials65. The 
use of CaPs in bone cements65,66 and adhesives67 is advantageous due to their ability 
to dissolve, diffuse and then precipitate in highly saturated physiological solutions such 
as simulated body fluid (SBF)68. They can then undergo phase transition to form more 
stable mineral phases such as HA69 and, under certain conditions, promote 
osteogenesis or dentinogenesis70,71. 
CaPs have also been extensively investigated in dental restoratives72, including 
monocalcium phosphate (MCP, Ca(H2PO4)2)19, di calcium phosphate (DCP, CaHPO4)73, 
tricalcium phosphate (TCP, Ca3(PO4)2)19, tetra calcium phosphate (TTCP, 
Ca4(PO4)2O)57, hydroxyapatite (HA, Ca10(PO4)6(OH)2)74 and amorphous calcium 
phosphate (ACP)75-77. 
The chemical structures of MCP, DCP, TCP and HA are illustrated in Figure 2.13 and 
their physical properties are listed in Table 2.7. The d50 of the MCPM and β-TCP used 
in this thesis are also given. In the present research, MCP and TCP were incorporated 
PMMA nanofibers were found. It was because that the methacry-
loyl groups on Bis-GMA main-chain could take favorable interac-
tion with the methacryloyl groups on the side-chains of PMMA,
and the PMMA nanofibers were partly dissolved into the dental
monomers [27,28]. After photopolymerization, the linear PMMA
could inter-penetrate and entangle with the cross-linked resin net-
work to form a semi-IPN structure. However, when the PMMA con-
tent exceeded the dissolving capacity of dental monomers, some
extra PMMA nanofibers were sticked together in the composites
as shown in Fig. 4 (c).
Unlike PMMA nanofiber reinforced composites, both PAN and
PAN–PMMA nanofiber kept fiber configuration in the composites
(as shown in Fig. 5). However, distinguished difference was identi-
fied between the composites reinforced with PAN nanofibers and
PAN–PMMA nanofibers by observing the fracture surfaces. For
the PAN nanofiber reinforced composites, many pullout nanofibers
were observed with little resin on the surface, which implied weak
interfacial bonding between nanofibers and matrix. On the con-
trary, nanofibers in PAN–PMMA composites (Fig. 5a and b) were
intimately adhered to the matrix on the fracture surfaces without
visible apparent boundaries between nanofibers and matrix, indi-
cating an enhanced interfacial bonding.
Just as PMMA nanofiber reinforced composites, PMMA located
in the shell structure of the PAN–PMMA nanofibers could also form
a semi-IPN structure with the dental resin. Therefore, an in situ
nano-interface between the PAN–PMMA nanofibers and matrix
was formed which resulted in good interfacial adhesion between
the nanofibers and resin matrix.
In order to know the formation of in situ nano-interface clearly,
a schematic representation on the formation of semi-IPN structure
of the composites was presented, as seen in Fig. 6. When the PAN–
PMMA nanofibers were immersed with the Bis-GMA/TEGDMA re-
sin, PMMA located on the shell could dissolve with the Bis-GMA
(Fig. 6b). After photopolymization, linear PMMA interpenetrated
and entangled with the crosslinked dental resin network (Fig. 6c)
and a semi-IPN structure was formed. It was reported that the
interaction between polymer molecular chains and the surface of
the nanofibers controls both the polymer molecular conformations
at the surface and the entanglement distribution in a larger region
surrounding the nanofibers [31–33]. For the PAN–PMMA nanofi-
bers, PMMA located in the shell structure, with a large surface to
volume ratio and just about 50 nm thicknesses can mostly dissolve
in Bis-GMA as shown in Fig. 6b. After photopolymization, most of
the PMMA chains entangled with the cross-linked dental resin net-
work in a larger region surrounding the nanofibers (Fig. 6c), and a
nano-interface was symmetrically and continuously formed be-
tween nanofibers and matrix, resulting in a flat configuration of
the polymer on the surface of the nanofibers and a compact inter-
face, as shown in Fig. 6d. Therefore, it is hard to find any pullout
PAN–PMMA nanofibers on the fracture surface of the composites.
The PAN–PMMA nanofiber composites not only introduce PMMA
in the shell structure to improve the interfacial adhesion in the
Fig. 5. SEM images of fracture surfaces of three-point flexural testing specimens: composite reinforced with different nanofibers. (a) low magnification of PAN–PMMA
nanofibers, (b) high magnification of PAN–PMMA nanofiber, (c) low magnification of PAN nanofiber, (d) high magnification of PAN nanofiber.
Fig. 6. Schematic representation of formation semi-IPN structure of the composite
(a) PAN–PMMA nanofiber (b) PMMA shell of nanofibers dissolved with the dental
resin (c) conform semi-IPN structure (d) chain entanglement of the interface to
form in situ nano-interface interaction.
3326 S. Lin et al. / Composites Science and Technology 68 (2008) 3322–3329
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into composites with the aim of inducing HA formation in order to remineralise gaps 
formed upon shrinkage which are susceptible to microleakage. In Chapter 4, a pilot 
study concerning the effects of CaPs on the physical properties of composites was 
carried out. The remineralising system was subsequently developed further in Chapter 
7. 
 
Figure 2.13. Chemical structures of various CaP phases. 
a) Monocalcium phosphate (MCP), (b) dicalcium phosphate (DCP), (c) tricalcium phosphate 
(TCP) and (d) hydroxyapatite (HA). MCP, shown in anhydrous form (MCPA), can also occur in 
monohydrate form (MCPM). DCP, shown in dihydrate form (DCPD), can also occur in 
anhydrous form (DCPA). 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.2.1.4 Antimicrobial agents 
Antimicrobial agents that have been investigated in remineralising dental composites 
and adhesives may be categorised into two main groups. Mobile antimicrobials are free 
to be released and include chlorhexidine diacetate (CHXA Figure 2.14a, Table 
2.8)18,19,68,78 and silver nanoparticles79-84. In contrast, cationic quaternary ammonium 
monomers are antimicrobial monomers that become immobilised within the polymer 
upon curing and protect against microbes in situ82,84-89. 
ε-poly-ʟ-lysine (εPL, Figure 2.14b, Table 2.8) is a basic, cationic homopolypeptide 
consisting of multiple L-lysine residues (~25–30 units in the present research). It is 
water-soluble, stable and biodegradable. The positively charged amine groups of εPL 
act by permeabilising the cell wall of a wide range of pathogens, including Gram-
positive and -negative bacteria, yeasts and moulds90-93. Furthermore, εPL is has low 
toxicity and is poorly absorbed by mammalian cells, even at high doses (e.g. 5 g/kg in 
Table 2.7. Physical properties of CaP phases. 
Component Mr ρ (g/cm3) RI 
MCPM 234 2.22 1.52 
DCPA 136 2.93 1.61 
DCPD 172 2.33 1.54 
β-TCP 310 3.06* 1.63 
HA 502 3.16 1.65 
* True value of whitelockite due to Fe & Mg 
content (theoretical value of β-TCP is 3.14) 
(a) (b) (c) (d) 
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rats). This enables its use as a broad-spectrum preservative in food, cosmetics and 
toothpaste (the US Food and Drug Administration authorises its use up to 50 mg/kg in 
food)93. 
The use of εPL in remineralising, antimicrobial composites is investigated in Chapter 7. 
 
Figure 2.14. Chemical structure of antimicrobial agents. 
(a) Chlorhexidine diacetate (CHXA) and (b) ε-poly-ʟ-lysine (εPL) (n ≈ 23–33). 
 
 
 
  
Table 2.8. Physical properties of antimicrobial agents. 
Component Mr 
CHXA 625.55 
εPL Variable 
(a) 
(b) 
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3 MATERIALS & METHODS 
3.1 Materials 
The sources of the components used are detailed in Table 3.1. Full names and 
locations of suppliers are listed in Table 3.2. 
 
  
Table 3.1. Composite component sources. 
Component Supplier Product [item code] 
 
Liquid Phase 
Monomer 
Bis-GMA Polysciences 2,2-Bis[4-(2-hydroxy-3-methacryloxypropoxy)phenyl]propane [03344] 
PPGDMA Polysciences Poly(propylene glycol) (400) dimethacrylate, 100 ppm MeHQ, 100 ppm BHT [04380] 
TEGDMA DMG Triethylene glycol dimethacrylate, 200 ppm MeHQ [100102] 
UDMA DMG Urethane dimethacrylate, 200 ppm MeHQ [100112] 
UDMA Esstech Urethane dimethacrylate, 100–200 ppm MeHQ [X850 0000] 
Photoinitiator 
CQ DMG Camphorquinone [100134] 
PPD Sigma-Aldrich 1-Phenyl-1,2-propanedione, 99% [223034] 
Co-initiator 
DMAEMA Sigma-Aldrich 2-(Dimethylamino)ethyl methacrylate, 98%, 700–1,000 ppm MeHQ [234907] 
DMPT Sigma-Aldrich 4,N,N-Trimethylaniline, 99% [D189006] 
EDAB Sigma-Aldrich Ethyl 4-aminobenzoate [112909] 
Mg-NTG-GMA Esstech NTG-GMA magnesium salt [X-863-0070] 
Na-NTG-GMA Esstech NTG-GMA sodium salt [X-863-0050] 
Inhibitor 
BHT Sigma-Aldrich Butylated hydroxytoluene [W218405] 
 
Filler Phase 
Non-reactive filler 
G0.7 DMG Silane-treated aluminoborosilicate glass particles, d50 = 0.7 µm [021110] 
G5 Sci-Pharm Silane-treated aluminoborosilicate glass particles, d50 = 5 µm [IF-2019] 
G7 DMG Silane-treated aluminoborosilicate glass particles, d50 = 7 µm [020684] 
OX-50 Evonik Aerosil® OX-50 hydrophilic fumed silica [OX-50] 
GF MO-SCI Silane coated, heat treated, aluminoborosilicate glass fibres   [GL-0271] 
Calcium phosphate 
MCPM Himed Monocalcium phosphate monohydrate, d50 = 53 µm [MCP-B26] 
DCPA Sigma-Aldrich Calcium phosphate dibasic [C7263] 
DCPD Fluka Calcium phosphate dibasic dihydrate [21184] 
β-TCP Plasma Biotal β-tricalcium phosphate, d50 = 16.9 µm [P292 S] 
Antimicrobial agent 
CHXA Sigma-Aldrich Chlorhexidine diacetate salt hydrate [C6143] 
εPL Handary Epolyly™ P Ultrapure ε-polylysine [0201] 
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3.1.1 Composite preparation 
3.1.1.1 Liquid phase preparation 
Liquid phases were prepared in amber (blue light proof) glass bottles. Inhibitor, co-
initiator and photoinitiator were first mixed with diluent monomer using a magnetic 
stirrer (Stuart UC151 or US151, Bibby Scientific, Stone, UK) until fully dissolved. Bulk 
monomer was then added and the liquid phase was stirred until homogeneous. The 
composition of the liquid phase varied depending on study, as outlined in each chapter. 
Liquid phases were stored at 4 °C and typically used to form composite pastes within 3 
months. Autopolymerisation was not observed over extended periods > 1 year. Future 
studies could test for autopolymerisation by testing the conversion of composite pastes 
that have been stored for varying time-points by Fourier transform infrared 
spectroscopy (FTIR, see Chapter 3.2.2.1) or after accelerating the ageing process by 
using high temperatures. 
Table 3.2. Composite component supplier locations. 
Supplier Location 
DMG Chemisch-Pharmazeutische Fabrik GmbH Hamburg, Germany 
Esscehm Europe Ltd. Seaham, UK 
Evonik Industries AG Essen, Germany 
Fluka Analytical (now Sigma-Aldrich Company Ltd.) Gillingham, UK 
Handary S.A. Brussels, Belgium 
Himed Old Bethpage, NY, USA 
MO-SCI Speciality Products, L.L.C. Rolla, MO, USA 
Plasma Biotal Ltd. Tideswell, UK 
Polysciences Inc. Eppelheim, Germany 
Sci-Pharm (Scientific Pharmaceuticals, Inc.) Pomona, CA, USA 
Sigma-Aldrich Company Ltd. Gillingham, UK 
Table 3.3. Physical properties of glass filler components. 
Filler ρ (g/cm3) RI Dimensions/distribution 
 
Bulk filler Particle distribution (µm) d10 d25 d50 d75 d90 
GP0.7 2.8 1.53 1.22 0.84 0.54 0.37 0.29 GP7 26.5 16.3 7.2 2.4 1.2 
GP5        
 
Fumed silica 
Particle  distribution 
(nm) Agglomerate  distribution (nm) 
d10 d50 d90 d10 d25 d50 d75 d90 
OX-50 2.2 1.46 ~20 ~40 ~70 11.3 20.9 80.3 156 177 
 
Glass fibre Fibre dimensions (µm) Diameter Length 
GF 2.6 1.55 ~15 ~300 
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3.1.1.2 Composite paste preparation 
Except where otherwise stated, dental composite pastes were prepared using a 
centrifugal planetary mixer (SpeedMixer, Hauschild Engineering, Hamm, Germany), in 
order to minimise air incorporation and to ensure complete wetting of filler particles. 
The liquid phase was first weighed in a circular mixing vessel with rounded corners and 
the filler phase was then placed on top. The composition of the filler phase and the 
powder to liquid ratio (PLR) varied depending on study, as outlined in each chapter. 
Batches of ~8–10 g composite were typically prepared. An optimised mixing 
programme was used (2,500 rpm for 10 s, followed by 1,000 rpm for 2 min). Composite 
pastes were stored in amber glass bottles at 4 °C and typically tested within 1 month. 
Composites containing a mixture of particle sizes, particularly those containing fumed 
silica, did not phase separate over extended periods of up to 1 year. The composites 
tested in Chapter 4 were mixed by hand using a stainless steel spatula and rubber 
mixing pad, since this work was carried out before the acquisition of the SpeedMixer. 
3.1.1.3 Disc specimen production 
Except where otherwise stated, disc-shaped specimens were moulded by applying 
composite pastes to metal circlips (internal diameter 10.2 mm, thickness 1 mm) and 
pressing them between two sheets of acetate. This prevents oxygen inhibition during 
polymerisation and expels excess paste, ensuring similar specimen thickness. 
Specimens were photo-polymerised using a blue light emitting diode curing unit with a 
wavelength of 450–470 nm and power output with periodic level shifting of 1,100–1,330 
mW/cm2 (Demi Plus, Kerr Dental, Orange, CA, USA), in direct contact with the acetate. 
The curing duration for each testing method varied and is detailed in each 
corresponding section. 
3.1.2 Storage media preparation 
Deionised water (dH2O, MicroPure, Barnstead, Thermo Scientific, Hemel Hempstead, 
UK), SBF and artificial saliva (AS) were used as storage media for some techniques, 
namely mechanical testing and analysis of water sorption and calcium phosphate 
precipitation. 
3.1.2.1 Simulated body fluid 
SBF was prepared according to BS ISO 23317:201294, using the formulation developed 
by Kokubo & Takadama (2006)95. Briefly, the components in Table 3.4 were gradually 
added to 700 mL dH2O in the order displayed in a plastic beaker. Each component was 
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fully dissolved before the next was added and a temperature of 36.5 ± 1.5 °C was 
maintained. Before tris(hydroxymethyl) aminomethane (TRIS) was added, the volume 
was topped up to 900 mL using dH2O. Temperature was then maintained at a more 
accurate 36.5 ± 0.5 °C and TRIS was added gradually. pH was not allowed to exceed 
7.45. HCl and TRIS were then added alternately, maintaining pH in the range of 7.42–
7.45. Once all of the TRIS had been dissolved, HCl was used to adjust the pH to 
exactly 7.40 at 36.50 °C. The solution was transferred to a 1 L volumetric flask and 
cooled to 20 °C, before the volume was finally adjusted. SBF was stored at 4 °C and 
used within 1 month. No spontaneous precipitation was observed during the storage 
period. 
Table 3.4. Composition of SBF. 
Component Mass (g) 
Sodium chloride 8.035 
Potassium chloride 0.355 
Dipotassium hydrogen phosphate trihydrate 0.225 
Magnesium chloride hexahydrate 0.231 
Hydrochloric acid solution, 1 M 39.00 
Calcium chloride dihydrate 0.292 
Sodium sulfate 0.072 
TRIS 6.118 
 
3.1.2.2 Artificial saliva 
AS was prepared according to the formulation used by McKnight-Hanes & Whitford 
(1992)96, with the exception of sorbitol, which was omitted because the viscosity of AS 
containing both sorbitol and cellulose is higher than typical saliva97. AS is unable to 
simulate the action of pellicle, due to the complexity of pellicle’s composition and 
patient to patient variability and from batch to batch, it does not suffer from the high 
variability seen between patients. Briefly, the components in Table 3.5 were added to 
dH2O in the order displayed. Each component was fully dissolved before the next was 
added. The pH was then adjusted to 6.75 using HCl or KOH. AS was stored at 4 °C 
and used within 1 month. 
Table 3.5. Composition of AS. 
Component Concentration (wt%) 
Methyl-p-hydroxybenzoate 0.2 
Sodium carboxymethyl cellulose 1 
Potassium chloride 0.0625 
Magnesium chloride hexahydrate 0.0059 
Calcium chloride dihydrate 0.0166 
Dipotassium phosphate 0.0804 
Monopotassium phosphate 0.0326 
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3.2 Methods 
3.2.1 Handling properties & wet-point determination 
The wet-point of various liquid and filler phase combinations was determined by 
gradually adding a small quantity of liquid phase to a known mass of filler phase and 
mixing, until the filler was sufficiently wetted and a cohesive paste had been formed. 
The quantity of liquid phase added was recorded and notes were made regarding the 
handling properties of each formulation. The wet-point (vol%) was then calculated from 
the total mass of liquid and the density of each component. 
3.2.2 Polymerisation properties 
3.2.2.1 Degree of conversion 
The conversion of composites was determined using Fourier transform infrared 
spectroscopy (FTIR, System 2000, PerkinElmer, Seer Green, UK). Composite paste 
was applied to either a single or four stacked circlips of the aforementioned 
dimensions. These were placed on the diamond of an attenuated total reflectance 
accessory (Golden Gate ATR, Specac, Slough, UK) and covered with a sheet of 
acetate. After an initial spectrum of the uncured composite had been obtained, spectra 
were recorded continuously for 1,000 s (n = 3). The specimens were photo-
polymerised from the top for the first 20 s. Spectra were recorded at a wavelength 
range of 800–1800 cm-1 and resolution of 8 cm-1. Absorbance profiles were obtained at 
1319 ± 1 cm-1 (C–O stretch bond) and 1334 ± 2 cm-1 (baseline) and used to calculate 
conversion at 1 mm and 4 mm depths using Equation 1,  
C = 1− 𝐴𝑓𝐴0 ×100 Equation 1 
where: C is conversion and Af and A0 are final and initial absorbance above baseline, 
respectively19. 
Example FTIR spectra are shown inFigure 3.1. 
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Figure 3.1. Example FTIR spectra. 
Spectra of experimental and commercial composites at various time-points, showing C–O 
stretch bond peak at 1319 cm-1 and its baseline at 1334 cm-1 in more detail. The broad peak at 
~1000 cm-1 represents the glass filler particles, the peaks of which vary greatly between 
manufacturers. Photoinitiation began at 0 s and progressed for 20 s. The spectra of 
subsequent time-points indicate that polymerisation continues beyond the curing period. 
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3.2.2.2 Polymerisation shrinkage 
Volumetric shrinkage was measured by two methods, in order to compare the reliability 
and convenience of the techniques. 
3.2.2.2.1 Shrinkage based on conversion 
Shrinkage was calculated from conversion data using Equation 298, which is based on 
the finding that methacrylate esters typically undergo volumetric shrinkage of ~22.5 
cm3/mol upon polymerisation99,100, 
S = 𝑚C𝜌 𝑛-𝑥-𝑊-- ×	2250 Equation 2 
where: S, m, C, ρ, Σ, i, n, x and W are shrinkage (vol%), monomer mass fraction 
within composite, conversion, composite density, sum of all monomers in liquid phase, 
each monomer in liquid phase, number of C=C bonds per molecule, mass fraction of 
monomer in liquid phase and molecular mass, respectively. 
3.2.2.2.2 Shrinkage based on volume change 
* This technique was performed by Dr. Wendy Xia (UCL Eastman Dental Institute) as 
her contribution to Ref. 101 * 
Shrinkage was obtained by measuring the density of polymerised and unpolymerised 
specimens according to BS EN ISO 17304:2013101,102. This technique uses an 
analytical balance equipped with a density determination apparatus (AG 204 & MS-
DNY-43, Mettler Toledo, Beaumont Leys, UK) and is based on Archimedes’ principle. 
Disc specimens were cured for 40 s from each side to ensure complete conversion. 
Specimen edges were polished to remove loose chips. The mass of three cured and 
three uncured specimens of each formulation were measured in air and under dH2O. 
Each value for mass under water was averaged from 10 readings. The shrinkage of 
composites and their SD were calculated using the equations provided in the standard. 
3.2.2.3 Depth of cure 
The depth of cure of composites (n = 3) was measured according to BS EN ISO 
4049:2009101,103. Briefly, composite paste was applied to a brass split-mould (internal 
diameter 4 mm, height 6 mm) and photo-polymerised for 20 seconds from the top. The 
specimen was removed from the mould and a plastic spatula was used to remove any 
uncured material from the bottom. The depth of cured material was measured using 
digital callipers to an accuracy of ± 0.01 mm and the reading was halved, as required 
by the standard, in order to give a value for depth of cure. 
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3.2.3 Quantification of mass and volume change 
Gravimetric analysis and Archimedes’ principal were used to quantity mass and 
volume change of composites in dH2O, SBF or AS at 37 °C (n = 3). Their mass in air 
and under dH2O was measured after 0, 2, 4 and 6 h and 1, 2, 4 and 7 days using an 
analytical balance equipped with a density determination apparatus (AG 204 & MS-
DNY-43, Mettler Toledo, Beaumont Leys, UK). In some studies, measurements 
continued to 14 days and 1, 2 and 3 months. After each time-point, specimens were re-
immersed in the same storage medium. Mass and volume change were plotted against 
time. The mass of dehydrated specimens was then determined in air and under dH2O, 
before being dehydrated again in preparation for SEM and EDX. The density of each 
specimen was calculated using Equation 3, in order to determine its volume using 
Equation 4, 
𝜌3 = 𝑚4𝑚4 − 𝑤4 𝜌6 − 𝜌7 + 𝜌7 Equation 3 𝑉 = 𝑚4𝜌3  Equation 4 
where: ρc, ρ0 and ρL are the density of the composite specimen, dH2O or air (g/cm3), 
respectively; mx and mi are the mass of the specimen in air at each specific time-point 
‘x’ and at the initial time-point, respectively; and V is the volume of the specimen (cm3). 
In Chapter 5, water sorption was simply determined by measuring the mass change of 
disc specimens cured for 40 s on each side after immersion in dH2O for 1 week. 
3.2.4 Scanning electron microscopy and energy dispersive X-ray 
spectroscopy 
Scanning electron microscopy (SEM, Philips XL30 Field Emission SEM, Amsterdam, 
Netherlands) was used to visualise mineral formation on the surface of composites. 
Specimens were coated with 95% gold and 5% palladium (Polaron E5000 Sputter 
Coater, Quoram Technologies, Laughton, UK) prior to imaging. Energy dispersive X-
ray spectroscopy (EDX, INCA Energy 400, Oxford Instruments, Abingdon UK) was 
used to quantify the ratio of calcium to phosphate in CaP precipitates on the surface of 
some composites, in order to estimate which CaP phase was present. Elemental 
proportions were averaged from maps obtained by EDX (n = 3), each containing 25 
spectra, attained at 10 µm intervals. 
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3.2.5 Raman spectroscopy 
* This technique was performed by Dr. Graham Palmer (UCL Eastman Dental 
Institute), a technician with experience in analysing Raman spectroscopy data, as his 
contribution to Ref. 104 * 
The composition of the surface of specimens (n = 3) was analysed by Raman 
spectroscopy, in order to confirm its chemical composition. A Raman spectrometer 
(LabRAM 300, Horiba UK Ltd., Northampton, UK) equipped with a 633 nm laser was 
used with grating set at 1800, a 50x objective and wavenumber range of 700 to 1650 
cm-1. Each specimen was mapped in three areas measuring 50 x 50 µm, with spectra 
obtained in 10 µm steps, providing 25 spectra per area, as previously described66. Run 
time and number were selected to ensure sufficient peak intensity above background 
and noise. Peak assignments were achieved by comparison with spectra of dental 
glass, liquid phase, εPL, MCPM, DCPA, DCPD, β-TCP and HA using LabRAM 
software (Horiba UK Ltd.). 
3.2.6 Mechanical and bonding properties 
3.2.6.1 Biaxial flexural test 
A biaxial flexural test was used to determine the biaxial flexural strength (BFS) and 
Young’s modulus of elasticity (E) of composites. In pilot studies, the modulus of 
toughness (UT) was assessed. Composite disc specimens (n = 5–10, depending on 
study) were cured for 40 s on each side. The majority of specimens were tested dry, 24 
h after curing. Others were stored dry for 24 h, before placement in 10 mL dH2O, AS or 
SBF at 37 °C for one week or one month. They were then tested (Autograph AGS-X, 
Shimadzu, Milton Keynes, UK), with a 2 kN load cell and ball-on-ring jig at a cross-
head speed of 1 mm/min, until specimen failure. Specimens in Chapter 4 were tested 
using the same parameters and jig but with a 1 kN load cell and a different test frame 
(4505 Series Universal Test Frame, Instron, High Wycombe, UK), as they were tested 
before the acquisition of the Autograph AGS-X. UT (MPa) was equal to the area under 
the stress strain curve. BFS (MPa) and E (GPa) were calculated using Equation 5105 
and Equation 6, respectively, 
BFS = 𝑃𝑡< 1 + 𝜐 0.485 𝑙𝑛 𝑎𝑡 + 0.52 + 0.48  Equation 5 𝐸 = ∆𝑃∆𝑤3 × 𝛽3𝑎<𝑡F  Equation 6 
where: BFS, P, t, υ and a are biaxial flexural strength, failure load (N), specimen 
thickness (mm), Poisson’s ratio (0.3) and jig support radius (4 mm); E, (ΔP/ΔWc) and 
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βc are modulus, gradient of elastic region and centre deflection function (0.5024)106, 
respectively. 
3.2.6.2 Shear bond test 
* This technique was performed by Dr. Saad Liaqat (UCL Eastman Dental Institute) as 
his contribution to Ref. 104 * 
Shear bond strength (τ) was assessed according to BS ISO 29022:2013107. Human 
dentine was collected from consenting, non-carious, adult human patients and stored 
at UCL Eastman Biobank (ID № 1304) according to ethical approval and the Human 
Tissue Act 2004. Uncut teeth were stored in a 0.2% thymol solution at 4 °C for up to 4 
weeks prior to use. Dentine was isolated from directly beneath the occlusal part of the 
enamel, as previously described108,109. Briefly, cut sections of human dentine were 
embedded in epoxy resin (SpeciFix 40, Struers, Rotherham, UK) with dentinal tubules 
aligned perpendicular to the resin surface. Care was taken to ensure that only 
superficial rather than deep dentine was exposed. After the resin had set, a cylindrical 
brass mould (6 mm depth, 3 mm internal diameter) was placed on the surface of the 
dentine. The end of the tube in contact with dentine was chamfered at 45°, in order to 
reduce its contact area. The dentine was etched using 37% phosphoric acid for 20 s, 
before being rinsed with dH2O and gently dried. Composite pastes were then applied in 
2 mm increments, with each layer being cured for 40 s before addition of the next. No 
bonding agent was utilised. τ was determined using a mechanical test frame (4505 
Series Universal Test Frame, Instron) equipped with a flat-edge shear fixture and 1 kN 
load cell (n = 3). The jig consisted of a metal holder with an adjustable screw for 
securing the specimen and an adjustable blade, which sheared the composite 
specimen from the dentine at a cross-head speed of 1 mm/min. τ was then calculated 
using Equation 7108, 
τ = 𝐹𝐴 Equation 7 
where: τ, F and A are shear bond strength, force and area, respectively. 
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3.2.7 Cytocompatibility 
3.2.7.1 Cell culture 
Primary human gingival fibroblasts (HGF) were obtained from a commercial source 
(ScienCell Research Laboratories, Carlsbad, CA, USA). HGF were cultured under 
standard conditions (37 °C, 95% air, 5% CO2, 95 % relative humidity) in Dulbecco’s 
modified Eagle medium (DMEM, Gibco, Life Technologies, Paisley, UK) supplemented 
with 10 % foetal bovine serum (FBS, Gibco) and 1 % penicillin/streptomycin (PAA 
Laboratories, GE Healthcare, Chalfont St. Giles, UK). Passage numbers 4–8 were 
used for cytocompatibility studies. 
3.2.7.2 Preparation of test solutions 
Test solutions were prepared in serum-free DMEM. As is typical in biomaterials testing 
and as recommended in ISO 10993110,111, serum-free medium was used in order to 
prevent adsorption of serum proteins to material components and alteration to release 
kinetics. Controls consisted of serum-free DMEM. Serum was not added to extracts 
after extraction and prior to cell culture. 
3.2.7.2.1 Liquid phase components 
Five ten-fold serial dilutions of each liquid phase component used in Chapter 5 were 
prepared in serum-free DMEM, ranging from 0.01–100 mM for DMAEMA, UDMA, 
PPGDMA and TEGDMA, and 0.001–10 mM for CQ and Bis-GMA, due to their lower 
solubility. The solutions were stored for ~30 mins at 60 °C and then stirred using a 
sterile spatula, in order to aid dissolution of components with low solubility, particularly 
the bulk monomers. 
3.2.7.2.2 Composite extracts 
In order to prepare specimens for extract testing, a 1 mm thick circlip atop a sheet of 
acetate was filled with composite and covered with acetate. A further three circlips 
were stacked on top and filled with composite and covered with acetate. The resultant 
4 mm deep stack was then photo-polymerised for 20 seconds from the top. The bottom 
1 mm thick section was removed from the mould and incubated in 650 µL serum-free 
DMEM at 37 °C. This provided an extraction ratio of 1 mL / 3 cm2 surface area, as 
required by ISO 10993-12:2009111. Specimens (n = 3) were agitated at 100 rpm during 
extraction (orbital shaker, Stuart Scientific, Stone, UK). After 24 h, specimens were 
transferred to fresh medium and incubated for a further 6 days, yielding extracts from 
1- and 7-day time-points. 
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3.2.7.3 Cytocompatibility assays 
HGF were seeded at a density of 30,000 cells/cm2 in 96 well plates (n = 3 per 
specimen, time-point and assay). After an initial 24 h seeding period, cell culture 
medium was replaced with 100 µL of the specimen (component solution, composite 
extract or control). The solutions were thoroughly mixed using a vortex mixer (Stuart 
SA8, Bibby Scientific, Stone, UK) in order to ensure even dispersion of dissolved 
components. Cytocompatibility was assessed after a further 24 h of culture (48 h time-
point), in accordance with ISO 10993-5:2012110. The specimen was then replaced with 
serum-free DMEM and cultured for a further 24 h recovery period (72 h time-point). 
This period was included in order to enable cells to recover after exposure to toxic 
components, indicating the severity of exposure on cell survival. 
Three water-soluble cell metabolic activity assays were used to assess 
cytocompatibility: resazurin (alamarBlue Cell Proliferation Assay, AdB Serotech, Bio-
Rad Laboratories Inc., Hemel Hempstead, UK); water-soluble tetrazolium salt-8 (WST-
8, Cell Counting Kit-8, Sigma-Aldrich); and 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-
methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS, CellTiter 96 AQueous One 
Solution Cell Proliferation Assay, Promega, Southampton, UK). Medium was aspirated 
from the cells and replaced with 100 µL fresh cell culture medium containing the 
corresponding substrate (Table 3.6). After incubation at 37 ˚C, fluorescence (FLx800 
Plate Reader, BioTek, Potton, UK) or absorbance (Infinite M200 Plate Reader, Tecan, 
Männedorf, Switzerland) was measured. Standard curves were obtained by seeding a 
range of cell concentrations in 96 well plates in serum-containing medium, 2 h prior to 
each assay, in which time the cells were observed via light microscopy to have 
attached and spread. 
Table 3.6. Cytocompatibility assay parameters. 
Substrate Incubation time (min) Measurement 
Resazurin, 10% 90 Fluorescence – excitation: 560 nm, emission: 590 nm 
WST-8, 10% 80 Absorbance – 460 nm (reference: 650 nm) 
MTS, 20% 60 Absorbance – 490 nm (reference: 630 nm) 
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3.2.8 Multifactorial analysis 
In order to establish whether any interaction effects occurred between components, 
pilot studies (Chapter 4.3) were analysed using multifactorial analysis according to 
Equation 8, 𝑃 =	< 𝑃 > ±𝑎M ± 𝑎< ± 𝑎F ± 𝑎M,< ± 𝑎M,F ± 𝑎<,F ± 𝑎M,<,F 𝑤ℎ𝑒𝑟𝑒	2𝑎- =	< 𝑃 >R−< 𝑃 >7 Equation 8 
where P = property, <P> = mean property, a = variable, H = high variable, and L = low 
variable. 
3.2.9 Statistical analyses 
Parametric one-way analysis of variance (ANOVA) and post-hoc Tukey’s tests were 
used (OriginPro software, OriginLab Corporation, Northampton, MA, USA) to 
determine significance (p ≤ 0.05) between composite formulations within a single study 
in Chapter 5–7. Non-parametric two-way ANOVA and post-hoc Tukey’s tests were also 
used in order to determine the significance of the effects of multiple factors, e.g. UDMA 
vs. Bis-GMA and PPGDMA vs. TEGDMA. Anderson-Darling test was used to 
determine normality. In all cases, except where otherwise indicated, the data had a 
Gaussian (normal) distribution. For all techniques, the standard deviation (SD) of each 
formulation was displayed on graphs, except in the case of polymerisation shrinkage, 
where the SD was averaged for each study, due to the high variability of the volume 
change method. Statistical significance is presented on graphs (* p < 0.05, ** p < 0.01, 
*** p < 0.005 or **** p < 0.001). 
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4 PILOT STUDIES: OPTIMISATION OF COMPOSITIONS 
4.1 Introduction to Chapter 4 
Chapter 4 concerns the results obtained from various pilot studies which were carried 
out in order to determine the feasibility of the project and in order to optimise certain 
aspects of the formulations studied in later chapters. This chapter deals with a wide 
range of considerations regarding composite formulations and these topics are 
investigated further in subsequent chapters. The list below summarises the factors that 
were analysed: 
• Wet-point 
- Effect of glass filler particle size 
• Mechanical properties 
- Feasibility of using UDMA as bulk monomer 
- Effect of diluent monomer (PPGDMA or TEGDMA) 
- Effect of co-initiator (DMPT, EDAB, Mg-NTG-GMA or Na-NTG-GMA) 
- Effect of PLR (3:1, 3.5:1 or 4:1) 
- Effect of GF (0, 5 or 20 wt% in filler phase) 
- Effect of glass filler particle size 
- Effect of CaPs (MCP and/or β-TCP at 0, 2.5, 10 or 20 wt% each in filler phase, 
alone or together at 1:1 wt ratio) 
- Effect of εPL (0, 0.5 or 5 wt% in liquid phase) 
• Water sorption 
- Effect of CaPs (MCP and/or β-TCP at 0 or 20 wt% each in filler phase, alone or 
together at 1:1 wt ratio) 
- Effect of εPL (0 or 5 wt% in liquid phase) 
4.2 Formulations 
Composites in Chapter 4 were hand-mixed and mechanical tests were performed using 
the 4505 Series Universal Test Frame, since these pilot studies were performed before 
the acquisition of the SpeedMixer and Autograph AGS-X. 
All Chapter 4 materials were left for 24 h to set or post-cure before mechanical testing. 
In Chapter 4.3.1, the mechanical properties of commercial composites G-ænial (GC 
Corporation), Gradia Direct Posterior (GC Corporation), Filtek Z250 (3M ESPE) and 
 60 
 
 
Filtek Z500 (3M ESPE) were first assessed. GIC Fuji IX GP (GC Corporation) and 
RMGIC Fuji II LC (GC Corporation) were also compared. The GIC was prepared 
according to the manufacturers’ guidelines. The RMGIC was mixed according to 
guidelines but cured for 40 s for closer comparison to the composites. 
The composition of the liquid phase of pilot study experimental formations was varied 
according to study, but the general formulation consisted of 1 wt% CQ, 1 wt% co-
initiator, 5 wt% HEMA, 23.25 wt% diluent monomer and 69.75 wt% UDMA. The ratio of 
bulk to diluent monomer was 3:1 by weight. PLR and filler phase composition was 
varied according to study. 
Table 4.1. Chapter 4 general composite formulations. 
Component 
type/parameter Component 
Quantity within 
phase 
 
Liquid phase 
Bulk to diluent monomer ratio 3:1 w/w 
Bulk monomer UDMA 69.75 wt% 
Diluent monomer PPGDMA or TEGDMA 23.25 wt% 
Bifunctional monomer HEMA 5 wt% 
Photoinitiator CQ 1 wt% 
Co-initiator DMPT, EDAB, Mg-NTG-GMA or Na-NTG-GMA 1 wt% 
 
Filler phase 
Glass particles GP0.7, GP5 or GP7 Up to 100 wt% 
Glass fibres GF 0, 5 or 20 wt% 
CaP MCPM 0, 2.5, 10 or 20 wt% β-TCP 0, 2.5, 10 or 20 wt% 
Antimicrobial εPL 0, 0.5 or 5 wt% 
PLR  3:1, 3.5:1 or 4:1 w/w 
 
In Chapter 4.3.2, the mechanical properties of composites containing co-initiators 
DMPT, EDAB, Mg-NTG-GMA and Na-NTG-GMA at 1 wt% of the liquid phase were 
compared. The diluent monomer was TEGDMA. The filler phase was 100 wt% GP5. 
Table 4.2. Chapter 4.3.2 composite formulations. 
Component 
type/parameter Component 
Quantity within 
phase 
 
Liquid phase variable parameters 
Co-initiator DMPT, EDAB, Mg-NTG-GMA or Na-NTG-GMA 1 wt% 
 
Liquid phase constant parameters 
Bulk monomer UDMA 69.75 wt% 
Diluent monomer TEGDMA 23.25 wt% 
Bifunctional monomer HEMA 5 wt% 
Photoinitiator CQ 1 wt% 
Co-initiator DMPT 1 wt% 
 
Filler phase constant parameters 
Glass particles GP5 100 wt% 
PLR  3.5:1 w/w 
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In Chapter 4.3.3, the effect of PLR and fibre content on mechanical properties was 
assessed. The mechanical properties of composites containing a PLR of 3:1, 3.5:1 or 
4:1 and with GP5 and GF at 100 and 0% or 80 and 20% of the filler phase, respectively, 
were compared. The diluent monomer and co-initiator were TEGDMA and DMPT, 
respectively. 
Table 4.3. Chapter 4.3.3 composite formulations. 
Component 
type/parameter Component 
Quantity within 
phase 
 
Filler phase variable parameters 
Glass particles GP5 80 or 100 wt% 
Glass fibres GF 0 or 20 wt% 
PLR  3:1, 3.5:1 or 4:1 w/w 
 
Liquid phase constant parameters 
Bulk to diluent monomer ratio 3:1 by weight 
Bulk monomer UDMA 69.75 wt% 
Diluent monomer TEGDMA 23.25 wt% 
Bifunctional monomer HEMA 5 wt% 
Photoinitiator CQ 1 wt% 
Co-initiator DMPT 1 wt% 
 
In Chapter 4.3.4, the effect of glass particle size on wet-point and mechanical 
properties was assessed. Composites containing 100 wt% of either G0.7, G5 or G7 were 
compared. Composites containing G0.7 and G7 at 1:2, 1:1 or 2:1 weight ratios were also 
compared. For the mechanical test, a PLR of 4:1 was used, except in the case of the 
composite containing 100 wt% G0.7 in its filler phase, which was tested at a PLR of 
2.5:1 due to its poor wettability. The diluent monomer and co-initiator were PPGDMA 
and Na-NTG-GMA, respectively. 
Table 4.4. Chapter 4.3.4 composite formulations. 
Component 
type/parameter Component 
Quantity within 
phase 
 
Filler phase variable parameters 
Glass particles 
GP0.7 100 wt% 
GP5 100 wt% 
GP7 100 wt% 
GP0.7:GP7 1:2 w/w 
GP0.7:GP7 1:1 w/w 
GP0.7:GP7 2:1 w/w 
PLR  Variable 
 
Liquid phase constant parameters 
Bulk to diluent monomer ratio 3:1 w/w 
Bulk monomer UDMA 69.75 wt% 
Diluent monomer PPGDMA 23.25 wt% 
Bifunctional monomer HEMA 5 wt% 
Photoinitiator CQ 1 wt% 
Co-initiator Na-NTG-GMA 1 wt% 
 
In Chapter 4.3.5, the interaction effects of glass fibres (5 or 20 wt% of filler phase), 
CaPs (MCPM and β-TCP combined at a 1:1 wt ratio, total 0, 20 or 40 wt%) and εPL 
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(0.5 or 5 wt%) and the effect of diluent monomer (PPGDMA or TEGDMA) were 
assessed in terms of the mechanical properties of composites. GP7 constituted the 
remainder of the filler phase. The PLR was 4:1. The co-initiator was Na-NTG-GMA. 
Table 4.5. Chapter 4.3.5 composite formulations. 
Component 
type/parameter Component Quantity within phase 
 
Liquid phase variable parameters 
Diluent monomer PPGDMA or TEGDMA 23.25 wt% 
 
Filler phase variable parameters 
Glass fibres GF 5 or 20 wt% 
CaP MCPM:β-TCP at 1:1 w/w 0, 5, 20 or 40 wt% total 
Antimicrobial εPL 0.5 or 5 wt% 
Glass particles GP7 Remainder of filler phase 
 
Liquid phase constant parameters 
Bulk to diluent monomer ratio 3:1 by weight 
Bulk monomer UDMA 69.75 wt% 
Bifunctional monomer HEMA 5 wt% 
Photoinitiator CQ 1 wt% 
Co-initiator Na-NTG-GMA 1 wt% 
 
Filler phase constant parameter 
PLR  4:1 by weight 
 
Finally, in Chapter 4.3.6, the effects of individual or combined CaPs (0 or 20 wt% 
MCPM and 0 or 20 wt% β-TCP) and εPL (0 or 5 wt%) on water sorption over three 
months and on mechanical properties after one week, two weeks and three months 
were analysed. GP7 constituted the remainder of the filler phase. The PLR was 4:1. 
The diluent monomer and co-initiator were PPGDMA and Na-NTG-GMA, respectively. 
Table 4.6. Chapter 4.3.6 composite formulations. 
Component 
type/parameter Component Quantity within phase 
 
Filler phase variable parameters 
CaP MCPM 0 or 20 wt% β-TCP 0 or 20 wt% 
Antimicrobial εPL 0 or 5 wt% 
Glass particles GP7 Remainder of filler phase 
 
Liquid phase constant parameters 
Bulk to diluent monomer ratio 3:1 by weight 
Bulk monomer UDMA 69.75 wt% 
Diluent monomer PPGDMA 23.25 wt% 
Bifunctional monomer HEMA 5 wt% 
Photoinitiator CQ 1 wt% 
Co-initiator Na-NTG-GMA 1 wt% 
 
Filler phase constant parameter 
PLR  4:1 by weight 
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4.3 Results 
4.3.1 Comparison of commercial composites 
The mechanical properties of commercial composites are shown in Figure 4.1. The 
GIC Fuji IX GP and RMGIC Fuji II LC both had very low BFS of 29 and 58 MPa, 
respectively. Gradia had a BFS of 97 MPa. Its successor G-ænial was slightly weaker 
at 86 MPa. Filtek Z250 and its successor Z500 had similar strength of ~178 MPa. The 
two Filtek products also had similar E (~4.5 GPa), higher than the remaining products 
which had similar E of ~2.5 GPa. UT increased from ~1–12 MPa in the same order as 
BFS increased: Fuji IX GP < Fuji II LC < G-ænial < Gradia < Z250 < Z500. 
 
 
Figure 4.1. Mechanical properties of commercial GIC, RMGIC and composites. 
(a) BFS, (b) E and (c) UT of dry specimens. Error bars represent 95% confidence interval (n = 
4–7).  
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4.3.2 Effect of co-initiator on mechanical properties 
The mechanical properties of composites containing various co-initiators are shown in 
Figure 4.2. Altering the co-initiator appeared not to have any significant effect on BFS 
(153–166 MPa) or E (4.1–4.5 GPa). Composite containing Na-NTG-GMA had 
approximately double the UT (25.3 MPa) value of the remaining composites (13.6–16.3 
MPa). 
  
  
Figure 4.2. Mechanical properties of composites containing various co-initiators. 
(a) BFS, (b) E and (c) UT of dry composite specimens containing 1 wt% DMPT, EDAB, Mg-
NTG-GMA or Na-NTG-GMA in the liquid phase. Error bars represent 95% confidence interval 
(n = 5–7).  
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4.3.3 Effects of PLR and GF content on mechanical properties 
The mechanical properties of composites containing varying PLRs (3:1, 3.5:1 or 4:1) 
and varying GF content (0 or 20 wt%) are shown in Figure 4.3. Neither the PLR used 
nor the inclusion of fibres had a significant effect on BFS (153–164 MPa). E varied 
from 4.2–5.2 GPa and was slightly higher in composites containing GF. The E of 
composites with a PLR of 3:1 was slightly lower than that of composites with a higher 
proportion of polymer. GF appeared to improve the mean UT of composites, though this 
was not statistically significant due to large variation in results. 
  
 
Figure 4.3. Mechanical properties of composites with varying PLR and GF content. 
(a) BFS, (b) E and (c) UT of dry composite specimens containing 0 or 20 wt% GF in the filler 
phase and PLR of 3:1, 3.5:1 or 4:1 by weight. Error bars represent 95% confidence interval (n = 
4–6).  
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4.3.4 Comparison of glass filler particle size 
4.3.4.1 Wet-point 
The wet-point of composites containing various glass filler particles (GP0.7, GP5, GP7 or 
combinations or GP0.7 and GP7 at 1:2, 1:1 or 2:1 wt ratios) are presented in Table 4.7. 
The wet-point is presented both as the wt% of filler in the composite at the wet-point 
and the equivalent PLR. It is worth noting that these values represent the absolute limit 
at which a cohesive paste could be formed but that a slightly lower wt% filler should be 
incorporated to enable improved wetting and handling properties. 
GP0.7 had the lowest wet-point (79 wt%), due to its large surface area to weight ratio. 
GP7 had a high wet-point (84 wt%), though that of GP5 was higher (87 wt%). As GP5 is 
produced by a different manufacturer than GP0.7 or GP7, it likely has a slightly different 
formulation with either higher density or greater silane content. 
The wet-points of the combinations of GP0.7 and GP7 at wt ratios of 2:1, 1:1 and 1:2 
were 81 wt%, 82 wt% and 85 wt% respectively. GP7 and the GP0.7:GP7 1:2 combination 
had sufficiently high wet-points for incorporation of additional, unsilanised fillers such 
as CaPs and εPL but had the best handling properties. Despite its high wet-point, GP5 
was not investigated further due to supply issues. 
Table 4.7. Wet-point of composites 
containing various glass fillers. 
Glass particle size Wet point 
(wt ratio) wt% PLR 
GP0.7 79 3.8:1 
GP5 87 6.7:1 
GP7 84 5.2:1 
GP0.7:GP7 (2:1) 81 4.1:1 
GP0.7:GP7 (1:1) 82 4.6:1 
GP0.7:GP7 (1:2) 85 5.5:1 
 
4.3.4.2 Mechanical properties 
The mechanical properties of composites containing various glass filler particles (GP0.7, 
GP5, GP7 or combinations or GP0.7 and GP7 at 1:2, 1:1 or 2:1 wt ratios) are shown in 
Figure 4.4. The PLR was constant at 4:1, except for composites containing only GP0.7, 
which had a PLR of 2.5:1 due to the low wet-point of the filler. Composites containing 
GP0.7 only had marginally higher strength (172 MPa) than those containing GP5 or GP7 
only (~154 MPa), which may have been due to more complete wetting at the lower 
PLR used. Composites containing a 1:1 wt ratio combination of GP0.7 and GP7 had the 
highest BFS (180 MPa), which is likely to be due to more efficient packing of the 
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particles during mixing. This formulation also had the highest E (5.5 GPa) and this did 
not impact negatively on its UT (26 MPa). 
Subsequent pilot studies utilised GP7 alone, due to its high wet-point and the greater 
convenience of using a single glass filler. 
  
 
Figure 4.4. Mechanical properties of composites with varying glass filler size. 
(a) BFS, (b) E and (c) UT of dry composite specimens containing GP0.7, GP5 or GP7, or 
combinations of GP0.7 and GP7 at 2:1, 1:1 or 1:2 wt ratios. PLR was 4:1, except for composites 
containing GP0.7 only (2.5:1). Error bars represent 95% confidence interval (n = 5–7). 
 
4.3.5 Effects of GF, CaP, εPL and diluent monomer on mechanical 
properties 
The mechanical properties of composites containing TEGDMA with varying GF (5 or 20 
wt% in filler phase), CaP (5 or 20 wt%, with MCPM and β-TCP at 1:1 wt ratio) and εPL 
(0.5 or 5 wt%) content are shown in Figure 4.5. Formulations containing 5 wt% εPL 
generally had lower BFS than those containing 0.5 wt%. CaPs at high levels (20 wt%) 
weakened the material unless combined with 20 wt% GF. When CaPs and GF were 
incorporated at 20 wt% each, BFS remained as high (133 MPa) as the formulation with 
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low levels of all components, suggesting an interaction effect between CaPs and GF. 
Formulations containing 20 wt% CaPs in general had lower E than those with 5 wt%. 
Increasing GF or CaP content resulted in notable increases in UT. In the case of the 
formulation containing 0.5 wt% εPL and 20 wt% each CaPs and GF, toughness was 
increased by approximately two-fold compared to most other formulations. 
The mechanical properties of composites containing PPGDMA with varying GF (0 or 
20 wt% in filler phase), CaP (0 or 40 wt%, with MCPM and β-TCP at 1:1 wt ratio) and 
εPL (0 or 5 wt%) content are shown in Figure 4.6. The trends observed in the previous, 
similar experiment were mirrored in this experiment. The differences between 
formulations were the diluent monomer (PPGDMA instead of TEGDMA), the high level 
of CaP (40 wt% instead of 20 wt%) and the low level of all components (0 wt% in all 
cases). Incorporating CaPs at 40 wt% and GF at 20 wt% had a significant effect on 
reducing E to ~2–2.6 GPa and increasing UT to 39 MPa. High BFS (126 MPa) was 
retained in the formulation containing low εPL and high CaPs and GF. 
Parts b, d and f of these figures illustrate the effects of individual components and 
interaction effects between components on mechanical properties, as calculated using 
Equation 8. They show the 2ai values, which are achieved by subtracting the average 
value of the low component concentration from the average value of the high 
component concentration. Positive values on the graphs indicate that either a single 
component or a combination of components which interact with one another cause in 
increase in the corresponding property. Similarly, a negative value indicates a 
reduction in value. Neutral values or those close to the x axis indicate no significant 
effect. 
Combined analysis of these results from both studies indicates that GF increased BFS 
and UT. CaPs decreased BFS and E, a trend which was slightly more pronounced in 
the latter study where CaP content was 40 instead of 20 wt%, but slightly increased UT. 
CaPs and GF interacted with one another to slightly improve BFS, without having a 
notable effect on E or UT. εPL reduced the values of all mechanical properties and did 
not have any clear interaction with other components. Due to the multiple factors being 
varied between studies, no conclusions could be made about the effect of varying the 
diluent monomer, though PPGDMA appeared to perform similarly to TEGDMA. 
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Figure 4.5. Mechanical properties of composites containing TEGDMA with varying GF, 
CaP and εPL content. 
(a,b) BFS, (c,d) E and (e,f) UT of dry composite specimens containing 5 or 20 wt% GF, 5 or 20 
wt% CaPs (MCPM and β-TCP at 1:1 wt ratio) and 0.5 or 5 wt% εPL in their filler phases and 
diluent monomer TEGDMA. (b,d,f) Effects of individual components and interaction effects 
between components. Error bars represent 95% confidence interval (n = 6–7).  
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Figure 4.6. Mechanical properties of composites containing PPGDMA with varying GF, 
CaP and εPL content. 
(a,b) BFS, (c,d) E and (e,f) UT of dry composite specimens containing 0 or 20 wt% GF, 0 or 40 
wt% CaPs (MCPM and β-TCP at 1:1 wt ratio) and 0 or 5 wt% εPL in their filler phases and 
diluent monomer PPGDMA. (b,d,f) Effects of individual components and interaction effects 
between components. Error bars represent 95% confidence interval (n = 5–8). 
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For example, formulations containing GF (e–h) have a much larger area under their 
stress-strain curves than those lacking GF. Their point of failure is much less 
pronounced than those of more brittle samples such as (a). CaPs also improve 
toughness but weaken the materials. 
 
 
 
 
Figure 4.7. Stress-strain curves of composites containing PPGDMA with varying GF, CaP 
and εPL content. 
PPGDMA-based composites with	powder phases containing (a–d) 0 or (e–h) 20% GF, (a,b,e,f) 
0 or (c,d,g,h) 40% CaPs (MCPM and β-TCP at 1:1 wt ratio) and (a,c,e,g) 0 or (b,d,f,h) 5% εPL 
(5–8 replicates per formulation are shown). 
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4.3.6 Effects of MCPM, β-TCP and εPL during storage in artificial saliva 
4.3.6.1 Mass and volume change 
The mass and volume change of composites containing PPGDMA with varying MCPM 
(0 or 20 wt% in the filler phase), β-TCP (0 or 20 wt%) and εPL (0 or 5 wt%) content 
over three months storage in AS are shown in Figure 4.8. This study assesses the 
individual and combined effects of each CaP on water sorption in AS, compared to 
previous studies which show the effect of total CaP content where the MCPM:β-TCP is 
kept constant at 1:1. Due to the large number of sample groups, the figure is split to 
facilitate viewing. The top two graphs show composites without εPL, whereas groups in 
the bottom two graphs include 5 wt% εPL. 
Composites lacking CaPs and εPL increased in mass by ~0.5 wt% after one week and 
~1% after one month. When εPL was incorporated at 5 wt%, mass increased by ~2 
wt% after one week and almost 4 wt% after one month. Composites containing 20 wt% 
β-TCP and lacking MCPM and εPL increased in mass by ~1 wt% after one week and 
1.2 wt% after one month. When εPL was incorporated, mass increased by ~3 wt% 
after one week and ~5 wt% after one month. Composites containing 20 wt% MCPM 
and lacking β-TCP and εPL increased in mass by 2.5 wt% after one week and 3.2% 
after one month. When εPL was incorporated, mass increased by ~5 wt% after one 
week and then plateaued. Composites containing 20 wt% of each CaP and lacking εPL 
increased in mass by ~7.4 wt% after one week and levelled off. When εPL was 
incorporated, this value was slightly lower (6.5 wt%). This was the only formulation that 
did not exhibit a significant increase when εPL was added. 
β-TCP alone did not induce extra mass or volume increase, likely due to its low 
solubility, though it did when combined with εPL, likely due to the high solubility of εPL. 
MCPM induced significantly more change than β-TCP. This could be due to its higher 
solubility increasing water sorption, which was further boosted by εPL. The formulation 
containing both CaPs at 20 wt% each exhibited significantly higher mass and volume 
increase than all other composites and this was not increased further by εPL. The 
density of specimens did not change significantly over the course of one month and no 
trends were observed (0.9978 ± 0.0005 g/cm3). 
An increase in mass may be due to absorbed water expanding the polymer and/or 
filling pores. Since no precipitation of mineral was observed on the surface of the 
composite, it is less likely to be due to CaP precipitating from the AS. Mass decrease 
may be due to diffusion of MCPM out of the material and replacement with water, since 
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the density of water is less than half that of MCPM (H2O ≈ 1 g/cm3; MCPM ≈ 2.2 
g/cm3). β-TCP has relatively low solubility and is therefore unlikely to dissolve or induce 
water sorption. 
 
 
 
  
Figure 4.8. Mass and volume change of composites with varying MCPM, β-TCP and εPL 
content over three months storage in AS. 
(a,c) Mass and (b,d) volume change of composite specimens containing 0 or 20 wt% GF, 0 or 
40 wt% CaPs (MCPM and β-TCP at 1:1 wt ratio) and 0 or 5 wt% εPL in their filler phases and 
diluent monomer PPGDMA over 3 months storage in AS. Composites (a,b) without and (c,d) 
with 5 wt% εPL. Error bars represent SD (n = 3).  
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4.3.6.2 Mechanical properties 
The mechanical properties of composites containing PPGDMA with varying MCPM (0 
or 20 wt% in the filler phase), β-TCP (0 or 20 wt%) and εPL (0 or 5 wt%) content after 
one week, two weeks and three months storage in AS are shown in Figure 4.9, Figure 
4.10 and Figure 4.11, respectively. Very similar trends were observed at all time-points, 
indicating that any effect due to storage in AS would have already occurred within the 
first week in most cases. There were two exceptions to this. The BFS of composites 
containing both CaPs reduced slightly between one and two weeks, whilst composites 
containing all three reactive fillers had increased in strength again by the final time-
point. The higher variability at the three month time-point is due to the low number of 
replicates (n = 3), since specimens were taken from the end-point of the water sorption 
study. 
As observed in the previous pilot study, εPL reduced strength of the material. β-TCP 
reduced BFS by ~20%, whilst MCPM had a greater effect, reducing it by ~56%. 
Materials containing both CaPs at 20 wt% each had the lowest BFS (34 and 49 MPa 
with and without 5 wt% εPL). The E and UT of composites followed the same trends as 
BFS. 
Parts b, d and f of these figures illustrate the effects of individual components and 
interaction effects between components on mechanical properties. MCPM significantly 
reduced BFS, E and UT, whereas β-TCP and εPL each reduced these values to a 
lesser degree. No clear interaction effects were observed.  
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Figure 4.9. Mechanical properties of composites with varying MCPM, β-TCP and εPL 
content after one week storage in AS. 
(a,b) BFS, (c,d) E and (e,f) UT of composite specimens containing 0 or 20 wt% MCPM, 0 or 20 
wt% β-TCP and 0 or 5 wt% εPL in their filler phases after 1 week storage in AS. (b,d,f) Effects 
of individual components and interaction effects between components. Error bars represent 
95% confidence interval (n = 8–9).  
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Figure 4.10. Mechanical properties of composites with varying MCPM, β-TCP and εPL 
content after two weeks storage in AS. 
(a,b) BFS, (c,d) E and (e,f) UT of composite specimens containing 0 or 20 wt% MCPM, 0 or 20 
wt% β-TCP and 0 or 5 wt% εPL in their filler phases after 2 weeks storage in AS. (b,d,f) Effects 
of individual components and interaction effects between components. Error bars represent 
95% confidence interval (n = 7–9).  
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Figure 4.11. Mechanical properties of composites with varying MCPM, β-TCP and εPL 
content after three months storage in AS. 
(a,b) BFS, (c,d) E and (e,f) UT of composite specimens containing 0 or 20 wt% MCPM, 0 or 20 
wt% β-TCP and 0 or 5 wt% εPL in their filler phases after 3 months storage in AS. (b,d,f) 
Effects of individual components and interaction effects between components. Error bars 
represent 95% confidence interval (n = 3).  
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4.4 Discussion 
This series of pilot studies was developed to give primary indications as to the effect of 
each component on the properties of the composites. Statistical analysis was not 
performed in detail in the current chapter but in Chapters 5–7 instead, where some of 
these properties were investigated in greater detail. Furthermore, the hypotheses that 
formed the basis for this chapter have already been discussed throughout the 
introduction and description of the components (Chapters 1–2) and are described in 
greater detail in Chapter 5–7, with detailed references to supportive literature. 
It was hypothesised that composites containing diluent monomer PPGDMA would have 
greater cytocompatibility than those containing TEGDMA without having significantly 
reduced mechanical properties, due to its higher molecular mass enabling greater 
flexibility and conversion. Since PPGDMA has not previously been investigated in 
dental composites, this hypothesis was completely novel and based on the chemical 
properties of the monomers in question. Composites containing 25 and 75 wt% diluent 
and bulk monomer, respectively, in their liquid phases have comparable mechanical 
properties regardless of whether PPGDMA or TEGDMA is used as diluent monomer. 
PPGDMA should theoretically have higher conversion than TEGDMA, due to its 
increased flexibility. This should theoretically result in improved cytocompatibility 
without increasing shrinkage, due to the lower double bond concentration of PPGDMA 
than TEGDMA. The use of PPGDMA in place of TEGDMA is therefore investigated in 
greater detail in Chapter 5. 
Although Bis-GMA was not compared to UDMA in this series of pilot studies, the use of 
UDMA as the sole bulk monomer resulted in relatively high strength composites. The 
use of UDMA in place of Bis-GMA may be beneficial, since it is a more flexible 
molecule. This should result in reduced viscosity, improved handling properties and 
greater conversion28,112. The use of UDMA in place of Bis-GMA is therefore also 
investigated in greater detail in Chapter 5. 
It was also hypothesised that different co-initiators would induce varying levels of 
conversion. No significant difference in BFS was noted between different co-initiators 
(DMPT, EDAB, Mg-NTG-GMA and Na-NTG-GMA). Composites containing Na-NTG-
GMA-Na had double the toughness of those containing the other co-initiators, which is 
likely due to its ability to bind to the polymer, which may in turn improve 
cytocompatibility and adhesiveness. The lack of difference in strength of composites 
containing different composites may be because all were combined at a sufficiently 
high concentration (1 wt%), above the threshold at which increasing the concentration 
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further would have a strong effect. A more effective comparison may be drawn by 
incorporating the co-initiators at a constant molar concentration, as opposed to 
proportion by mass. The effects of photoinitiator and co-initiator are therefore 
investigated in greater detail in Chapter 6. 
It is worth noting that when comparing components in these pilot studies, they were 
incorporated at a fixed wt% of the liquid phase. This makes direct comparison difficult. 
For example, Na-NTG-GMA has Mr of 329, almost 2.5 times greater than that of DMPT 
(135). This means that Na-NTG-GMA achieved similar properties to DMPT despite 
being incorporated at only 40 mol% of the concentration than DMPT was used at. 
Similarly, fewer molecules of PPGDMA than TEGDMA were present when the mass 
ratio of bulk to diluent monomer was kept fixed at 3:1. For this reason, subsequent 
studies were improved by using a fixed molarity or molar ratio in order to give a clearer 
insight into the effects of each component. 
It was hypothesised that differences between glass filler particle sizes and surface 
treatments (which likely vary between manufacturers) would have a significant effect 
on the wet-point of the composites54. Glass particle size had a significant effect on 
wettability of the filler phase, due to the relationship between surface area per g of filler 
and the proportion of monomer required. Silanisation and density of the glass may also 
play an important role, since differences in the handling properties of GP5 and GP7 
were noticeable despite their similar particle sizes. 
Furthermore, it was hypothesised that glass fibres would improve the toughness of 
composites62-64. GF alone slightly improved UT without affecting strength. Both CaPs 
reduced BFS when used alone or together. However, when CaPs and fibres were 
combined at high levels, UT was significantly improved. This is likely to be due to an 
interaction between the CaP fillers and the CaP that exists in GF. CaPs may therefore 
be used in combination with fibres to provide a toughening and remineralising 
capability to the composite. Despite this, GF were not studied further due to concerns 
over poor wear resistance, due to the large size of the fibres. 
β-TCP and MCPM have previously been shown to promote DCPD and HA mineral 
precipitation on the surface of composites in SBF68. Due to their high solubility, MCPM, 
and to a greater extent εPL, induced water sorption and release of CaPs out of the 
material in AS. In a super-saturated solution such as SBF or dentinal fluid, this may 
result in precipitation of stable HA. Clinically, this could occur at microscopic debonding 
sites between the tooth and the restoration and help to remineralise and potentially 
even “self-repair” the material, ultimately resulting in reduced rates of recurrent caries 
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and restoration failure. At the high levels studied here, these components contribute to 
the weakening of the material in artificial saliva. These components could, however, be 
more finely tuned and incorporated at more moderate levels, in order to achieve this 
remineralising effect. 
The use of antimicrobial εPL may also help to prevent recurrent caries. Unpublished 
data suggests that εPL is released in sufficient quantities and over a prolonged period 
of one month to have an inhibitory effect on microbes (personal communication with 
Dr. Anne Young, Dr. Wendy Xia and Dr. Mohammed Adnan Khan due to a pending 
patent application113 and development of a commercial product preventing publication 
of these data). εPL may be advantageous over CHXA due to its more complete 
release. It may also cause less tooth discolouration than CHXA, although the 
concentration of CHXA released from composites is significantly lower than that 
incorporated into commercially available Corsodyl gum treatment mouthwash. 
Although it causes a slight decrease in BFS, if used at moderate levels this should not 
be detrimental to the material. Furthermore, by inducing water sorption, εPL may act 
synergistically with CaP to encourage CaP release and subsequent remineralisation. 
The use of εPL in dental composites is novel. The effects of MCPM, β-TCP and εPL 
are therefore investigated in greater detail in Chapter 7. 
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5 EFFECT OF MONOMER VARIATION ON CYTOCOMPATIBILITY 
AND MATERIAL PROPERTIES 
Note: Chapter 5 is the subject of the following publication (Ref. 101): 
Walters NJ, Xia W, Salih V, Ashley PF & Young AM. Poly(propylene glycol) and 
urethane dimethacrylates improve conversion of dental composites and reveal 
complexity of cytocompatibility testing. Dental Materials 2016;32:264–77, doi: 
10.1016/j.dental.2015.11.017. 
5.1 Introduction to Chapter 5 
Despite being favoured by clinicians for their high strength compared to other tooth-
coloured filling materials and supreme aesthetics compared to all other filling materials, 
the physical characteristics of dental composites are limited by the close interplay 
between monomer conversion and characteristics such as polymerisation shrinkage, 
water sorption, mechanical properties, elution of toxic components and 
biocompatibility. In order to achieve optimal biocompatibility, mechanical properties and 
aesthetics114, a high degree of conversion is ideal, since these properties are directly 
affected by the level of residual monomer remaining in the composite after curing. 
Conversely, however, high conversion results in high volumetric shrinkage of 
dimethacrylate-based composites. For the patient, this can result in microbial 
microleakage, subsequent recurrent caries and, ultimately, failure of the restoration. 
Monomers with low double bond concentration can therefore be used in order to 
minimise shrinkage. This is of particular importance for bulk fill materials, which are 
applied in thicker increments. The incremental layering of composites, which requires 
curing each increment before applying the next, is time-consuming for clinicians. This 
is especially true of deep posterior cavities, which would require multiple increments. 
As a result, bulk fill materials are often used to overcome this issue. Bulk fill 
composites utilise photoinitiators which are effective at depths of ~4–5 mm in 
combination with monomers that have low double bond concentration. 
The research presented in Chapter 5 aimed to improve the conversion, strength and 
cytocompatibility of dimethacrylate-based composites without detrimentally affecting 
their shrinkage or depth of cure. This was approached by replacing Bis-GMA with 
UDMA and TEGDMA with PPGDMA. It was hypothesised that the greater cross-linking 
density and flexibility of UDMA than Bis-GMA28,112 would help to improve conversion 
and therefore better cytocompatibility without increasing conversion or depth of cure. 
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Similarly, PPGDMA was hypothesised to achieve similar improvements due to its 
significantly lower double bond concentration and greater flexibility than TEGDMA. 
Human gingival fibroblasts (HGF) were cultured in solutions of each individual liquid 
phase component at varying concentrations, as well as in extracts of each composite 
formulation, in order to investigate the effect of each monomer on cytocompatibility. 
Due to variability between different assays arising from the targeting of different 
metabolic enzymes115, three cell viability assays were compared. 
5.2 Formulations 
Composites were prepared using a filler phase with a fixed formulation, consisting of 
10 wt% OX-50, 30 wt% GP0.7 and 60 wt% GP7. This was combined with four 
dimethacrylate-based liquid phases. The liquid phases consisted of bulk monomer 
UDMA or Bis-GMA combined with diluent monomer PPGDMA or TEGDMA, prepared 
according to Chapter 3.1.1.1. The bulk to diluent molar ratio was 3.5:1. This 
corresponded to the wt ratios show in Table 5.1. The liquid phases also contained 40 
mM (0.58–0.61 wt%) CQ, 60 mM (0.82–0.86 wt%) DMAEMA and 100 ppm BHT. 
Pastes were prepared according to Chapter 3.1.1.2 and disc specimens produced 
according to Chapter 3.1.1.3 were used for studies, except where otherwise indicated 
in specific method subsections. PLR was kept constant at 40 vol% liquid (19.3–20.3 
wt%, depending on liquid phase density). Dental composites were designated 
abbreviations based on their bulk and diluent monomer content: UP, UT, BP and BT, 
where U, B, P and T represent UDMA, Bis-GMA, PPGDMA and TEGDMA, 
respectively. Formulations are summarised in Table 5.1. Filtek Z250 was used for 
comparison. 
Table 5.1. Chapter 5 experimental formulations. 
 
Variable liquid phase parameters 
Formulation Bulk monomer Diluent monomer Bulk:diluent monomer wt ratio 
UP UDMA PPGDMA 3.09:1 UT TEGDMA 5.96:1 
BP Bis-GMA PPGDMA 3.44:1 BT TEGDMA 6.67:1 
 
Fixed liquid phase parameters 
Bulk to diluent monomer ratio 3.5:1 
CQ 40 mM 
DMAEMA 60 mM 
BHT 100 ppm 
  
Fixed filler phase and PLR parameters 
GP0.7 30 wt% 
GP7 60 wt% 
OX-50 10 wt% 
PLR  40 vol% liquid 
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5.3 Results 
5.3.1 Handling properties and wet-point 
The experimental formulations all had wet-points of 33.3 ± 0.4 vol% liquid. When 
produced at their corresponding wet-points, composite pastes containing Bis-GMA 
were perceived to be considerably less malleable during specimen moulding than 
those containing UDMA. Composites produced at 40 vol% liquid were slightly more 
malleable, though those containing Bis-GMA were still less malleable than those 
containing UDMA. The handling properties of Z250 were between those of Bis-GMA- 
and UDMA-containing composites. A difference in handling properties was not 
observed between PPGDMA- and TEGDMA-containing composites. 
5.3.2 Polymerisation properties 
5.3.2.1 Conversion 
On average, UDMA-containing experimental composites had 1.2 and 1.3 times higher 
conversion than Bis-GMA-containing composites at 1 and 4 mm depth, respectively 
(average p-value of both depths = 0.001) (Figure 5.1a). Use of PPGDMA in place of 
TEGDMA increased conversion by a further 1.1 and 1.2 times at 1 and 4 mm, 
respectively (average p-value of both depths < 0.01). Of all four experimental 
formulations, UP had the highest conversion, at 68% and 65% at 1 and 4 mm. The 
conversion of UP at both depths was significantly higher than that of BP, BT and Z250 
(p < 0.001). At 1 mm, it was significantly higher than that of UT (p < 0.05). Z250 had 
the lowest conversion of 50% and 39% at 1 and 4 mm, whilst that of BT was 
comparable. The conversion of Bis-GMA-containing composites (BP, BT and Z250) 
was significantly lower at 4 mm than at 1 mm. 
5.3.2.2 Shrinkage 
The shrinkage at 1 mm depth of UDMA-containing experimental composites was 
estimated to be ~1.2 times higher, on average, than of Bis-GMA-containing composites 
(p < 2 x 10-5), when calculated based on conversion values obtained at 1 mm depth 
(Figure 5.1b). TEGDMA-containing composites were estimated to have ~1.1 times 
higher shrinkage than PPGDMA-containing composites (p < 0.04). The shrinkage of 
Z250 could not be calculated by this method because its exact composition is not 
publicly available. The values obtained by measuring volume before and after curing, 
however, indicated no statistically significant effect of monomer on shrinkage (including 
Z250), due to the high standard deviation of the technique.  
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Figure 5.1. Polymerisation properties of composites with varying monomers.  
(a) Conversion at 1 and 4 mm depth. Columns represent mean, error bars represent SD. 
(b) Shrinkage of 1 mm thick composite discs, calculated from conversion or volume change. 
Columns represent mean, error bars represent mean SD of the corresponding technique (± 
0.05 and ± 0.23 vol% for conversion and volume change, respectively).  
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Figure 5.1 (continued). Polymerisation properties of composites with varying monomers.  
(c) Depth of cure of composites. 
(d) Mass increase of composites after immersion in dH2O for one week. 
(c, d) Crosses represent mean, boxes represent 25–75 percentiles, error bars represent SD.  
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5.3.2.3 Depth of cure 
All composites had highly comparable depths of cure of 2.7 ± 0.25 mm, regardless of 
monomer composition (F = 0.96) (Figure 5.1c). 
5.3.2.4 Water sorption 
TEGDMA-containing composites had, on average, 1.2 times higher water sorption than 
that PPGDMA-containing composites (p < 0.02) (Figure 5.1d). UDMA induced ~1.1 
times greater water sorption than Bis-GMA, though this was not deemed statistically 
significant. UT absorbed significantly more water than Z250 and BP (p < 0.05). 
5.3.3 Mechanical properties 
Experimental composites containing UDMA had significantly higher strength (153–158 
MPa) than those with Bis-GMA (p = 1x 10-7). BP (127 MPa) was significantly stronger 
than BT (99 MPa) (p < 0.05) (Figure 5.2a). Composites containing PPGDMA had 
slightly lower E, on average, than those with TEGDMA (6.15 and 6.75 GPa, 
respectively) (p = 0.009) (Figure 5.2b). Z250 was the strongest composite (173 MPa) 
and had the lowest modulus (5.3 GPa). 
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Figure 5.2. Mechanical properties of composites with varying monomers. 
(a) Biaxial flexural strength and (b) modulus of tensile elasticity after storage in dH2O at 37 ˚C 
for one week. Crosses represent mean, boxes represent 25–75 percentiles, error bars 
represent SD. The BPS of BP did not have normal distribution according to the Anderson-
Darling test but had normal distribution according to others (Kolmogorov-Smirnov and Lilliefors 
tests). The E of UP and UT did not have normal distribution according to the Anderson-Darling 
test but had normal distribution according to the Kolmogorov-Smirnov normality test. 
  
 88 
 
 
5.3.4 Cytocompatibility 
5.3.4.1 Comparison of resazurin, WST-8 and MTS assays 
The apparent cell density of HGF after being cultured in serum-free DMEM for 48 and 
72 h is shown in Figure 5.3. An increase in apparent cell density from 30,000 to 
~49,000 cells/cm2 between 0 and 48 h was indicated by resazurin and WST-8 assays. 
MTS, however, reported a smaller increase in apparent cell density from 30,000 to 
37,000 cells/cm2. After 72 h, the resazurin assay reported a cell density of 113,000 
cells/cm2, much higher than the 74,000 cells/cm2 reported by the WST-8 assay and the 
45,000 cells/cm2 reported by MTS. Due to the notable differences in cell densities 
measured in these control samples, subsequent data were normalised to the 
corresponding assay’s control and time-point. The results from the cytocompatibility 
studies are reported in terms of ‘relative metabolic activity’ in order to emphasise the 
differences between assays. 
 
Figure 5.3. Initial seeding density of HGF. 
Determined by cell counting (0 h, cross), and apparent density after culture in DMEM for 48 h 
(unfilled symbols) and 72 h (filled symbols), as assessed by resazurin (circle), WST-8 (triangle) 
and MTS (square) assays. Error bars represent SD.  
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5.3.4.2 Composite component cytocompatibility 
The relative metabolic activity of HGF surviving exposure to liquid phase components, 
prepared at various concentrations, followed by a subsequent recovery period, is 
presented in Figure 5.4. Dashed lines represent the mean control value for pure 
DMEM, from each corresponding assay and time-point. All of the liquid phase 
components tested caused concentration-dependent reductions in cell number 
associated with increasing concentrations, as expected. The extent of this relationship, 
however, varied between assays. In all assays, every component at a concentration of 
10 mM or higher caused complete loss of metabolic activity. 
5.3.4.2.1 CQ 
At the 48 h time-point, a direct correlation between CQ concentration and WST-8 
activity was apparent, with ≤ 0.01 mM causing no significant decrease (Figure 5.4a). At 
0.1, 1 or 10 mM, reductions in WST-8 activity of 17, 33 and 98% occurred, 
respectively. At most concentrations, similar levels (± 5%) of resazurin activity were 
measured after 48 h, but these did not change significantly by 72 h. By comparison, 
MTS activity was up to 15% higher after 48 h and further elevated after 72 h, at ~10–
38% greater than the control, except at concentrations ≥ 10 mM. After 72 h, similar 
WST-8 activity to the control (± 7%) was measured at all concentrations except at 
concentrations ≥ 10 mM, which appeared to cause cell death. 
5.3.4.2.2 DMAEMA, TEGDMA & UDMA 
In contrast to CQ, 0.01 mM DMAEMA caused an 86–95% reduction in metabolic 
activity in all assays by 48 h and cell populations did not recover by 72 h (Figure 5.4b). 
≥0.1 mM was sufficient to cause total inhibition of MTS, resazurin and WST-8 activity, 
clearly indicating that cell death had occurred. A concentration of 0.01 mM UDMA 
(Figure 5.4c) or TEGDMA (Figure 5.4f) was sufficient to inhibit all enzymes. 
5.3.4.2.3 Bis-GMA 
Bis-GMA appeared to have higher cytocompatibility than the other three monomers 
(Figure 5.4d). After 48 h, concentrations in the range of 0.001 and 0.01 mM appeared 
to have no effect on WST-8 metabolism, although activity increased by 7 and 66% 
upon increasing concentrations to 0.1 and 1 mM, respectively. Both other assays 
showed similar trends, except that at 0.001 and 0.1 mM, values reported by resazurin 
and MTS were lower by ~10–15% and ~23–28%, respectively. WST-8 activity 
increased by between 7 and 20% between 48 and 72 h, except at 10 mM, and activity 
at concentrations of 0.001–0.1 mM appeared to be greater than the corresponding 
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controls. The values recorded for resazurin activity were similar at both time-points (± 
10%). 
5.3.4.2.4 PPGDMA 
The trends of HGF metabolic activity upon exposure to PPGDMA were more complex 
(Figure 5.4e), with all three assays giving varying results. MTS, resazurin and WST-8 
metabolism were fully inhibited within 48 h by ≥10 mM PPGDMA and cells did not 
recover thereafter. A small increase in MTS and WST-8 activity occurred upon 
reducing concentration, though values remained well below those of the corresponding 
controls and cells did not appear to proliferate by 72 h. Interestingly, resazurin activity 
in PPGDMA solutions below 0.1 mM at 48 h was higher than for the control, later falling 
to control levels by 72 h. After 48 h, at 0.01–1 mM, PPGDMA caused reduction in 
WST-8 activity of 76, 85 and 92%, respectively, and these levels remained similar at 72 
h. MTS metabolism was also similar. Resazurin activity at PPGDMA concentrations of 
0.01 and 0.1 mM was 63 and 35% higher the control after 48 h, respectively. At 1 mM, 
it was comparable to the control. These values had fallen by 72 h, with resazurin 
activity at 0.01, 0.1 and 1 mM being ~12% greater, 7% lower and 80% lower than the 
control, respectively. 
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Figure 5.4. Relative metabolic activity of HGF after culture in liquid phase components. 
* Continued overleaf * 
 (a) CQ, (b) DMAEMA, (c) UDMA, (d) Bis-GMA, (e) PPGDMA or (f) TEGDMA. Resazurin (circle), 
WST-8 (triangle) and MTS (square) assays were performed after 24 h culture in the solutions 
(48 h time-point, unfilled symbols), and after a subsequent 24 h recovery period in DMEM (72 h 
time-point, filled symbols). Component concentrations ranged from 0.001–10 mM (a and d) or 
0.01–100 mM (b, c, e and f). Dashed lines represent the mean value of the control, error bars 
represent SD.  
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Figure 5.4 (continued). Relative metabolic activity of HGF after culture in liquid phase 
components. 
* Continued overleaf * 
 (a) CQ, (b) DMAEMA, (c) UDMA, (d) Bis-GMA, (e) PPGDMA or (f) TEGDMA. Resazurin (circle), 
WST-8 (triangle) and MTS (square) assays were performed after 24 h culture in the solutions 
(48 h time-point, unfilled symbols), and after a subsequent 24 h recovery period in DMEM (72 h 
time-point, filled symbols). Component concentrations ranged from 0.001–10 mM (a and d) or 
0.01–100 mM (b, c, e and f). Dashed lines represent the mean value of the control, error bars 
represent SD.  
 93 
 
 
 
Figure 5.4 (continued). Relative metabolic activity of HGF after culture in liquid phase 
components. 
(a) CQ, (b) DMAEMA, (c) UDMA, (d) Bis-GMA, (e) PPGDMA or (f) TEGDMA. Resazurin (circle), 
WST-8 (triangle) and MTS (square) assays were performed after 24 h culture in the solutions 
(48 h time-point, unfilled symbols), and after a subsequent 24 h recovery period in DMEM (72 h 
time-point, filled symbols). Component concentrations ranged from 0.001–10 mM (a and d) or 
0.01–100 mM (b, c, e and f). Dashed lines represent the mean value of the control, error bars 
represent SD.  
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5.3.4.3 Composite extract cytocompatibility 
HGF metabolic activity after culture in conditioned medium extracts of composites is 
presented in Figure 5.5. Similarly to the component assays, notable differences were 
observed between assays. From this point onwards, data are expressed as a 
percentage of the control for each corresponding extract (1 or 7 days) and assay time-
point (48 or 72 h), in order to facilitate description and elucidation of trends. 
A general downward trend in resazurin metabolism was observed after 24 h exposure 
to 1 day composite extracts (48 h time-point), in the following order: UP > UT ≥ BP > 
BT ≥ Z250. Despite WST-8 data differing slightly (UP ≈ UT > BP ≈ BT > Z250), both 
assays confirmed that the extracts from the deepest 1 mm of 4 mm thick composite 
specimens containing UDMA caused a lesser reduction in metabolic activity after 48 h 
than those containing Bis-GMA. This was statistically significant in the case of 
resazurin (p = 0.001). MTS showed no significant differences between experimental 
formulations. All assays indicated that Z250 had low cytocompatibility. In the case of all 
assays, metabolic activity varied from being similar to the control (UP) down to ~50% of 
the control (Z250). A small but significant reduction in resazurin activity was induced by 
TEGDMA extracts compared to PPGDMA extracts (p < 0.01), though WST-8 and MTS 
showed no clear trends with respect to the effect of diluent monomer. 
Activity of all three enzymes after culture of HGF for 72 h in all material extracts had 
fallen to approximately 50% that of the control. Z250 was the only material with 
observable differences between assays, with resazurin activity remaining similar to 
after 48 h (~50%), but WST-8 activity falling from 53 to 37% and MTS activity falling 
from 53 to 33%, though these differences were not statistically significant. 
As expected, resazurin and WST-8 indicated that 7 day extracts were more 
cytocompatible than 1 day extracts, as metabolic activity of HGF cultured in 7 day 
extracts returned to control levels by the 72 h time-point. The resazurin assay 
performed after 48 h on 7 day extracts gave similar trends to that performed on the 
corresponding 1 day extracts, though values were slightly higher. After 48 h incubation, 
for example, resazurin activity was ~75% relative to the control when HGF were 
cultured in 7 day BT extracts, compared to 56% in 1 day extracts. WST-8 activity in all 
material extracts was similar to the control or slightly elevated (up to 11%) after 48 h, 
except in the case of the 7 day extract of Z250, which caused significant reduction in 
WST-8 activity. Resazurin and WST-8 activity of HGF cultured in 7 day extracts had, in 
general, recovered by the 72 h time-point, though resazurin metabolism in BT and 
Z250 extracts remained slightly reduced at 89 and 82%, respectively. WST-8 activity 
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was between 10 and 31% greater than the control in all experimental formulation 
extracts after 72 h. In contrast, MTS activity in 7 day extracts was significantly different 
from that of resazurin and WST-8, at ~60–75% higher than the control at both time-
points. MTS activity in 7 day Z250 extracts was similar to WST-8. 7 day extracts of 
UDMA-containing composites also appeared to have improved cytocompatible 
compared to Bis-GMA-containing composites in all assays (48 h resazurin, p = 0.03; 72 
h WST-8, p = 0.0008; 72 h MTS, p = 0.007). Finally, WST-8 activity was significantly 
higher after exposure to 7 day extracts of PPGDMA-containing composites than 
TEGDMA-containing composites at 48 h (p = 0.04).  
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Figure 5.5. Relative metabolic of HGF after culture in composite extracts. 
* Continued overleaf * 
(a, c) 48 h or (b, d) 72 h culture in (a, b) 1 day or (c, d) 7 day extracts, assessed by resazurin 
(dark grey), WST-8 (black) and MTS (light grey) assays. Dashed lines represent the mean value 
of the control, error bars represent SD.  
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Figure 5.5 (continued). Relative metabolic of HGF after culture in composite extracts. 
* Continued overleaf * 
(a, c) 48 h or (b, d) 72 h culture in (a, b) 1 day or (c, d) 7 day extracts, assessed by resazurin 
(dark grey), WST-8 (black) and MTS (light grey) assays. Dashed lines represent the mean value 
of the control, error bars represent SD.  
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5.4 Discussion 
In the present chapter, composites containing bulk monomer UDMA or Bis-GMA with 
diluent monomer PPGDMA or TEGDMA were compared in terms of their material 
characteristics and cytocompatibility. As expected, UDMA-containing experimental 
formulations had significantly higher conversion and slightly improved cytocompatibility 
compared to Bis-GMA-containing formulations. Similarly, PPGDMA-containing 
composites had higher conversion than TEGDMA-containing composites. The use of 
UDMA and PPGDMA as the sole bulk and diluent monomers did not detrimentally 
affect shrinkage or depth of cure, and this use of UDMA in place of Bis-GMA improved 
handling properties. 
The proportions of OX-50 (10 wt%), G0.7 (30 wt%), reactive fillers (variable) and G7 
(remainder of filler phase) used were determined by pilot studies, which found this 
general formulation to have optimal handling properties and wettability. 
The differences in conversion of the four formulations followed the expected trends, 
based on differences in the chemical structures (Figure 2.4 and Figure 2.5) and 
physical characteristics (Table 2.4) of their constituent monomers. Despite being a 
slightly smaller molecule and subsequently having slightly higher double bond 
concentration (the ratio of double bonds per molecule to its molecular mass) than Bis-
GMA, the lower glass transition temperature (Tg) and greater flexibility of UDMA enable 
more complete cross-linking116. Bis-GMA contains bulky aromatic groups which cause 
steric hindrance and very high viscosity (~80 times that of UDMA), which reduces 
flexibility and limits the likelihood of methacrylate groups binding to one another. 
Conversely, PPGDMA, which is over double the molecular mass of TEGDMA, achieves 
greater conversion because of its greater flexibility and lower double bond 
concentration. 
The similar depth of cure of all formulations is likely due to the similar refractive indices 
of all the monomers, which was 1.48 ± 0.04, though results from using the standard 
protocol provide only limited information. BS EN ISO 4049:2009103 utilises a ‘scraping’ 
method, which likely suffers from variability between different researchers and is only a 
rough and highly subjective measurement of composite hardness versus depth. It does 
not provide any information regarding the level of conversion at different depths, or the 
depth at which ≥50% conversion was achieved. As such, the standard requires that the 
depth value obtained is divided by 2 in order to give an estimate of the depth of cure, 
which appears to result in under-reporting of depth of cure values for certain 
formulations. In general, it may be considered that a value of ≥50% conversion 
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indicates that, on average, one methacrylate group per monomer molecule has reacted 
– enough to claim that that the composite has cured and has acceptable 
cytocompatibility117. The first double bond of a dimethacrylate molecule tends to 
polymerise faster than the second, since the propagating polymer is more flexible 
earlier on when less cross-linking has taken place. In order to overcome the limitations 
of the standard protocol, FTIR was used in the current chapter in order to more 
accurately assess the depth of cure by associating it with the conversion at various 
specified depths. In contrast to the similar depths of cure of all formulations obtained by 
the standard (mean 2.7 ± 0.25 mm), the FTIR-ATR-based method confirmed that UP, 
UT and BP had ≥ 50% conversion at 4 mm depth, whereas BT and Z250 had 
conversion below 50%. This facile technique therefore offers greater insight into the 
inter-related topics of monomer conversion and depth of cure than the current standard 
protocol. 
The convenience and accuracy of the FTIR-ATR technique may be further exploited in 
order to overcome the high margin of error associated with the standard protocol for 
assessing shrinkage18. The standard protocol is based on measuring composite 
volume change and is highly sensitive to entrapment of air bubbles and instability of 
balance readings. While the standard protocol failed to elucidate any significant 
differences in the shrinkage of the composites, conversion-based calculations indicated 
that UDMA-containing composites have slightly higher conversion than Bis-GMA-
based composites, as expected based on their chemistry. Equation 1 (p. 53) is, 
however, based on the assumption that one mole of C=C bonds typically undergoes 
polymerisation shrinkage of ~22.5 cm3 99. It is important to note that this is a 
generalised value for methacrylates based on Bis-GMA-based monomers. It is unable 
to take into account possible differences arising from more complex physical 
properties, such as the flexibility or steric hindrance of different monomers. It also does 
not take into consideration that water may less readily penetrate some composites than 
others, based on pore size and the hydrophobicity of the materials. Despite this, the 
conversion calculation provides more reliable results without conflicting with those 
obtained using the standard protocol. 
Despite their high conversion of 62–67.5% and slightly higher double bond 
concentration than composites containing Bis-GMA, those containing UDMA had 
acceptable shrinkage of 2.55–2.86 vol%, regardless of which measurement technique 
was employed. A possible explanation for this is that the shrinkage of dimethacrylates 
upon polymerisation may be more strongly affected by the first methacrylate group 
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bonding than by the second. Additionally, despite its higher conversion, PPGDMA had 
slightly lower shrinkage than TEGDMA, on average. This is attributed to its much 
higher Mr and the subsequent lower double bond concentration that arises from this. 
A simplified version of BS EN ISO:2009 was used to estimate the water sorption of 
composites from their mass increase after storage in dH2O for one week. This enabled 
use of less material than the standard recommends. Bis-GMA induced slightly lower 
mass increase than UDMA, which is likely due to the hydrophobicity of its aromatic 
groups. Similarly, propylene glycol groups on PPGDMA are more hydrophobic than 
ethylene glycol groups on TEGDMA. This, combined with TEGDMA’s lower cross-
linking density, resulted in greater water sorption in TEGDMA-containing composites. 
The correlation between the conversion and BFS of experimental formulations was 
likely due to the improved entrapment of filler particles, which is likely to have occurred 
in composites with greater cross-linking. Furthermore, the interaction between the 
monomers and the short, aliphatic silane (3-(trimethoxysilyl)propyl methacrylate) 
coating on the fillers, which has relatively low hydrophobicity, is stronger with the 
aliphatic groups of UDMA, PPGDMA and TEGDMA than the aromatic groups of Bis-
GMA. Z250 ‘s higher BFS is likely due to differences in the fillers used, the composition 
of the liquid phase and the filler to liquid ratio, and no conclusions can be made without 
knowing its exact formulation. In comparison to previous studies, which have often 
explored wt ratios28, a fixed molar ratio of bulk to diluent monomer was used, in order 
to enable direct comparison of conversion and cytocompatibility. The relatively low 
proportion of diluent monomer used in this study likely explains why Z250 had 
significantly higher BFS than BP and BT. 
Although the densities of the monomers do not vary significantly, variations in Mr and 
viscosity result in noticeable differences in composite handling properties, as discussed 
in Chapter 2.3.1.1. This means that, when comparing composites with the same molar 
ratio of bulk to diluent monomer as opposed to wt ratio, handling properties were 
similar. 
Despite the low solubility of most of the liquid phase components analysed in this 
study, it was possible to dissolve them in cell culture medium at up to 10 mM (CQ and 
Bis-GMA) or 100 mM (DMAEMA, PPGDMA, TEGDMA and UDMA). Most components 
remained fully dispersed in the medium, although CQ and TEGDMA did settle at high 
concentrations. In order to ensure complete dispersal of the components, test solutions 
were thoroughly mixed by vortexing immediately prior to adding them to well plates. 
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Due to the limitations of cytocompatibility assays and variability between the different 
enzymatic substrates available115, the present study utilised three different assays 
(resazurin, WST-8 and MTS) in order to assess the cytocompatibility of composite 
liquid phase components and composite extracts. The reduction of all these three dyes 
is carried out by NADH and NADPH dehydrogenase enzymes in metabolically active 
cells, though the location of this activity varies, occurring within the mitochondria in the 
case of resazurin, in the cystoplasm in the case of MTS and extracellularly in the case 
of WST-8.  It is important to take into consideration that the values obtained by these 
assays do not report the true cell density, as may be determined by cell counting via 
staining and imaging techniques such as a live/dead assay. They are, instead, an 
estimate of cell density based on the metabolic activity of the corresponding enzyme, 
extrapolated from a standard curve from various cell concentrations. The nature of 
such assays means that they rely on the assumption that relative metabolic activity 
remains constant with time after cell seeding. It can be seen in Figure 5.3, however, 
that different assays reported different cell densities over time, even in the controls, 
despite having the same initial seeding density. For this reason, the cytocompatibility of 
the composite components and extracts was reported in terms of metabolic activity as 
a percentage of the corresponding control, for each assay and time-point. The use of 
serum-free medium did not noticeably limit the proliferative potential of HGF over the 
short duration of these assays (up to 48 h), since apparent cell density values fell 
within the expected range for HGF based on typical culturing conditions with FBS. 
CQ was shown to have good cytocompatibility. Given that it is present at low 
concentrations in the material, is unlikely to leach in large enough quantities to cause a 
toxic effect. DMAEMA was demonstrated to be highly cytotoxic. Unlike some other 
initiators such as DMPT, however, DMAEMAs methacrylate group enables it to 
become incorporated within the polymer, likely minimising its release. 
A wealth of studies have shown that dental monomers such as Bis-GMA, UDMA and 
TEGDMA cause cytotoxic, genotoxic and apoptotic responses in a variety of cell 
types33-37. Presence of excessive reactive oxygen species have previously been shown 
to arrest cell cycle at different phases in different fibroblast types upon exposure to 
these monomers35,118-122. As well as delaying cell cycle progression, these monomers 
also have an impact on proliferation and cell survival, as well as causing inflammation 
and/or necrosis. TEGDMA has also been shown to act as a vasorelaxant38-42 and to 
cause apoptosis and necrosis, which was associated with a reduction in cdc2, cyclin 
B1 and cdc25C expression and increase in p21 expression43 and upregulation of 
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caspases44. Bis-GMA induces inflammation and necrosis by upregulating expression of 
prostaglandin, tumour necrosis factor-a and various cell surface antigens123-125. As 
discussed in 2.3.1.1, although Bis-GMA is typically synthesised via BPA-free routes 
and is widely used in composites, there are concerns over its ability to gradually 
degrade via hydrolysis to form BPA32. Furthermore, toxic monomers can be released 
by enzymatic degradation, as well as mechanical abrasion37. 
It was hypothesised that by increasing the length of the diluent monomer by using 
PPGDMA instead of TEGDMA, it would be possible to alleviate oxidative stress to 
some degree126. In the present short-term study, HGF metabolised resazurin 
significantly more efficiently after exposure to PPGDMA, either in solution or via 
composite extracts, than after exposure to TEGDMA or UDMA. HGF failed, however, to 
efficiently metabolise WST-8 and MTS after exposure to any of these components, 
even at low concentrations. 
Bis-GMA had a lesser effect on metabolic activity of HGF than the other monomers, up 
to a concentration of at least 0.1 mM. Its TC50 value (the concentration at which 50% of 
cells survived) was in the range of ~0.5–1 mM, consistent with previous findings in 
HGF and HaCaT (keratinocyte cell line)127 and an order of magnitude greater than 
observed in some other cell lines, such as L929128,129. This highlights the potential for 
variability, which can arise between different cell types and methods of material 
preparation, culture duration, seeding density and other factors. Although neither the 
longer-term cytotoxic effects nor the genotoxic effects of Bis-GMA were investigated 
here, previous studies have demonstrated that the use of Bis-GMA in dental materials 
is cause for concern. The use of alternative monomers with excellent mechanical 
properties and relatively high viscosity, but with lower viscosity and improved handling 
properties compared to Bis-GMA would therefore be ideal. The TC50 of UDMA and 
TEGDMA could not be directly compared to previous findings, since even at the lowest 
concentration tested, fewer than 50% of cells were viable after 48 h. The TC50 values of 
UDMA (≤ 0.01 mM) and TEGDMA (< 0.01 mM) were notably lower, however, than 
previously observed, at ~0.06–4 mM119,127,129 and ~1–4.1 mM127,129, respectively. 
UDMA is also widely used in dental composites, typically in combination with Bis-GMA 
and/or similar high viscosity monomers. The use of UDMA has been shown to result in 
significantly higher conversion, more complete cross-linking and lower leaching of 
uncured monomer than Bis-GMA112, as well as higher flexural strength and 
hardness130. It has therefore been suggested that UDMA may be used as the sole bulk 
monomer in orthodontic adhesives28 and bone cements131. In the present Chapter, the 
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use of UDMA as the sole bulk monomer in a dental composite was investigated. It was 
hypothesised that its higher conversion would result in improved cytocompatibility due 
to reduced leaching of un-cross-linked monomers and initiators, such as the highly 
toxic DMAEMA. Despite UDMA being more cytotoxic than Bis-GMA to HGF in solution, 
the results of the 48 h resazurin and WST-8 assays suggest that 1 day extracts of 
UDMA-containing composites were more cytocompatible than those of Bis-GMA-
containing composites. After a subsequent recovery period, however, all three assays 
showed similar metabolic activity after exposure to all materials, suggesting that UDMA 
is similarly cytotoxic but has a delayed action. These findings may result from a 
combination of the greater presence of Bis-GMA and diluent monomers in the extracts, 
due to Bis-GMA’s poorer conversion, and UDMA’s higher cytotoxicity. 
Although water-soluble assays offer a convenient insight into the cytocompatibility of 
biomaterials, they have the drawback of being unable to differentiate between cells that 
are actively proliferating and cells that are in a quiescent state132. This is reflected in 
the over-estimation of cell density by the MTS assay in the present study. 
Overestimation and/or underestimation can also result from interference caused by the 
compound being analysed. Although resazurin133, WST-8134 and MTS135 have all been 
previously reported to overestimate and/or underestimate cell number, MTS appears to 
be particularly affected. In the present Chapter, the MTS assay’s significant 
underestimation of cell density in the control was most likely the cause of its 
overestimation of metabolic activity per cell. 
Further complications arise from the fact that different studies utilise varying cell types. 
Given their differing phenotypes and susceptibility to cytotoxic and genotoxic effects136, 
direct comparisons cannot be made. In addition, short-term cytocompatibility studies do 
not take into account possible genotoxic and mutagenic effects. Although it was 
beyond the scope of this study, future research into the longer-term cytotoxic and 
genotoxic effects of a wide range of commonly used composite components would be 
highly beneficial in elucidating the causes of the complex trends observed in this and 
other studies. Although an extensive range of such studies has been performed, the 
different parameters investigated between different research groups (material 
concentration, material preparation, extraction technique, cell type, assay, genes 
analysed and duration of study) make it difficult to directly compare results and 
definitively interpret them. Better understanding of the fundamental effects of each 
individual component is required in order to improve the biocompatibility of novel dental 
composites. A more systematic and wide-ranging approach would be beneficial in 
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establishing a library which comprehensively documents the effects of each 
component. 
More comprehensive studies are therefore required to elucidate the longer-term effects 
of monomers and composite extracts on a wide range of markers of biocompatibility in 
a variety of relevant cell types. This includes analysis of expression of cell surface 
markers and genes implicated in oxidative stress and apoptotic response, in parallel 
with multiple metabolic activity assays, live/dead analysis, quantification of total DNA, 
e.g. via CyQUANT cell proliferation assay, and the study of changes to cell morphology 
via imaging techniques. This type of broad library approach would enable more 
targeted design of novel composites with improved biocompatibility for improved 
treatment of dental caries. 
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6 EFFECTS OF PHOTO- AND CO-INITIATORS ON MATERIAL 
PROPERTIES AND CYTOCOMPATIBILITY 
6.1 Introduction to Chapter 6 
As discussed in Chapter 2.3.1, the conversion, depth of cure and mechanical 
properties of composites are affected by the photoinitiators and co-initiators used, as 
well as their concentrations. In general, these properties improve as concentrations of 
these components are increased, up to a certain threshold, after which they either 
plateau or decline. There are, however, associated detrimental effects of high 
photoinitiators and co-initiator concentrations, such as poor cytocompatibility resulting 
from subsequent leaching of these small, toxic compounds, or discolouration and 
decline in aesthetics of the composite. The present chapter therefore focuses on 
optimising photo- and co-initiator compounds and concentrations for use in Chapter 7. 
Furthermore, as mentioned in Chapter 2.3.1.3, PPD is able to act by both type I and 
type II photoinitiation mechanisms and has been shown to act synergistically when 
combined with CQ51. In Chapter 6.3.1, the conversion, depth of cure and mechanical 
properties of composites containing either CQ, PPD or a combination of both at a 1:1 
molar ratio (total concentrations 20, 40 or 60 mM) are determined, with 60 mM 
DMAEMA as the co-initiator. 
Since the conversion and cytocompatibility of composites is affected by the chemistry 
of the co-initiator used, these properties are assessed in composites containing either 
DMAEMA, DMPT, EDAB or Na-NTG-GMA at 60 mM in Chapter 6.3.2. 
6.2 Formulations 
Composites were prepared using the same filler phase and PLR as that in Chapter 5. 
This was combined with twelve dimethacrylate-based liquid phases prepared according 
to Chapter 3.1.1.1. These consisted of UDMA and PPGDMA at a molar ratio of 3.5:1, 
as in Chapter 5, with 100 ppm BHT and varying photo- and co-initiator concentrations. 
In the first set of studies, photoinitiator was varied. Varying CQ concentrations (20, 40 
and 60 mM) were incorporated into three composites, with DMAEMA remaining 
constant at 60 mM. Similarly, PPD was incorporated into three composites alongside 
DMAEMA at the same concentrations. In addition, CQ and PPD were incorporated 
together into three composites, each at 10, 20 and 30 mM (total 20, 40 and 60 mM 
photoinitiator in each formulation). In the second set of studies, the co-initiator used 
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was varied. CQ was incorporated into three composites at 40 mM, alongside either 
DMPT, EDAB or Na-NTG-GMA at 60 mM (with comparison to the previously described 
formulation containing 40 mM CQ and 60 mM DMAEMA). Pastes were prepared 
according to Chapter 3.1.1.2 and disc specimens produced according to Chapter 
3.1.1.3 were used for studies, except where otherwise indicated in specific method 
subsections. Formulations are summarised in Table 5.1. 
Table 6.1. Chapter 6 experimental formulations. 
 
Variable liquid phase parameters 
Photoinitiator(s) Photoinitiator concentration Co-initiator (60 mM) 
CQ 
20 mM 
DMAEMA 40 mM 
60 mM 
CQ + PPD 
10 mM each 
DMAEMA 20 mM each 
30 mM each 
PPD 
20 mM 
DMAEMA 40 mM 
60 mM 
CQ 40 mM 
DMPT 
EDAB 
Na-NTG-GMA 
 
Fixed liquid phase parameters 
UDMA:PPGDMA molar ratio 3.5:1 
BHT 100 ppm 
 
Fixed filler phase and PLR parameters 
GP0.7 30 wt% 
GP7 60 wt% 
OX-50 10 wt% 
PLR  40 vol% liquid 
 
6.3 Results 
6.3.1 Varying photoinitiator 
6.3.1.1 Polymerisation properties 
6.3.1.1.1 Conversion and depth of cure 
The mean conversion at 1 mm depth of the nine formulations with varying photoinitiator 
type and concentration was 70.9 ± 3.1% (Figure 6.1a). In general, increasing total 
photoinitiator concentration from 20 to 60 mM appeared to result in very slightly 
increased conversion. These differences were statistically significant (p ≥ 0.05) only 
between the formulations containing 10 mM CQ + 10 mM PPD and 30 mM CQ + 30 
mM PPD (p < 0.05). The mean conversion values of all composites containing 40 or 60 
mM photoinitiator were significantly higher than the mean values of those containing 20 
mM, regardless of the photoinitiator used. Furthermore, the mean conversion values of 
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composites containing CQ or a combination of CQ + PPD were greater than that of 
composites containing only PPD. 
The depths of cure of composites containing varying photoinitiator type and 
concentration are illustrated in Figure 6.1b. Composites containing CQ alone had a 
mean depth of cure of 2.72 ± 0.04 mm, regardless of CQ concentration. Composites 
containing 10 mM CQ + 10 mM PPD or 20 mM CQ + 20 mM PPD also had a mean 
depth of cure of 2.74 ± 0.04 mm, but this fell to a significantly lower 2.45 ± 0.05 mm in 
composites containing 30 mM CQ + 30 mM PPD (p < 0.005). Depth of cure of the 
formulation containing 20 mM PPD was poor, at 2.22 mm, but this rose to 2.58 and 
2.67 mm as concentration was increased to 40 and 60 mM, respectively. 
6.3.1.2 Mechanical properties 
The mechanical properties of composites with different photoinitiator types and 
concentrations are shown in Figure 6.2. The mean BFS of all formulations was 163 ± 
20 MPa. Though the BFS of composites containing only PPD appeared to increase 
slightly with increasing PPD concentration, this was not significant. There were no 
significant differences between BFS values of any formulation. In contrast, E increased 
in parallel with photoinitiator concentration, regardless of whether CQ, PPD or a 
combination was used, with mean values of each concentration having p values ≤ 
0.0018. The mean E value of PPD-containing composites was significantly higher than 
the mean of CQ (p = 1.09 x 10-6) or a combination (7.1 x 10-6). 
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Figure 6.1. Polymerisation properties of composites containing varying photoinitiators. 
(a) Conversion and (b) depth of cure of composites containing varying photoinitiator type (CQ, 
PPD or both) and concentration (20, 40 or 60 mM total) at 1 mm depth. Crosses represent 
mean, boxes represent 25–75 percentiles, error bars represent SD.  
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Figure 6.2. Mechanical properties of composites containing varying photoinitiators. 
(a) BFS and (b) E of dry composites containing varying photoinitiator type (CQ, PPD or both) 
and concentration (20, 40 or 60 mM total). Crosses represent mean, boxes represent 25–75 
percentiles, error bars represent SD.  
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6.3.2 Varying co-initiator 
6.3.2.1 Conversion 
There was no statistical difference between the conversion of experimental composites 
containing varying co-initiators at a fixed concentration of 60 mM, regardless of which 
photoinitiator or combination was used (Figure 6.3). Their mean value was 68.6 ± 
3.82%, though Na-NTG-GMA had higher SD than DMAEMA, DMPT and EDAB. All 
experimental formulations had significantly higher conversion than Z250 (p < 0.005). 
 
Figure 6.3. Polymerisation properties of composites containing varying co-initiators. 
Conversion of composites containing varying co-initiator type at 1 mm depth (DMAEMA, 
DMPT, EDAB or Na-NTG-GMA at 60 mM). Crosses represent mean, boxes represent 25–75 
percentiles, error bars represent SD.  
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6.3.2.2 Cytocompatibility 
The relative cell density of HGF following 48 h culture in extracts of composites 
containing various co-initiators is presented in Figure 6.4. WST-8 activity was 
significantly higher in all composite extracts compared to the extract- and serum-free 
DMEM control and was significantly higher in Na-NTG-GMA-containing composites 
compared to those containing DMAEMA, DMPT or EDAB. 
 
Figure 6.4. Cytocompatibility of composites containing varying co-initiators. 
Cytocompatibility of extracts of composites containing varying co-initiator type at 1 mm depth 
(DMAEMA, DMPT, EDAB or Na-NTG-GMA at 60 mM), assessed using WST-8 assay. Crosses 
represent mean, boxes represent 25–75 percentiles, error bars represent SD. 
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6.4 Discussion 
The physical properties of composites are directly determined by the efficiency of the 
polymerisation reaction, which in turn is determined by the type and concentration of 
photoinitiator and co-initiator. In order to optimise these properties and to improve 
understanding of the effect preliminarily investigated in the pilot studies (Chapter 4), 
photoinitiators CQ and PPD and co-initiators DMAEMA, DMPT, EDAB and Na-NTG-
GMA were investigated in various combinations based on molar concentrations, as 
opposed to the constant wt% previously investigated. 
It was hypothesised that increasing photoinitiator concentration would increase 
conversion up to a certain threshold, before plateauing137. A previous indication that 
CQ and PPD may work synergistically via their different photopolymerisation modes to 
improve depth of cure when combined together was also investigated51. As expected, a 
general increase in conversion was associated with an increase in photoinitiator 
concentration, though this trend was not statistically significant in most cases. The 
mean conversion value of all composites containing a total of 20 mM photoinitiator, 
however, was significantly lower than that of composites containing 40 or 60 mM. 
Furthermore, composites containing CQ with or without PPD had higher mean 
conversion than those containing only PPD. Depth of cure was consistently high in 
composites containing CQ at any concentration, whereas composites containing PPD 
with or without CQ had either similar or significantly lower depth of cure. 
BFS was unaffected by photoinitiator type and concentration. In contrast, the mean E 
was significantly higher in composites containing PPD only than in those containing CQ 
or both. Since composites with high conversion and depth of cure are favourable and 
those with high E are at greater risk of brittle fracture, 40 mM CQ was deemed the 
most optimal photoinitiator type and concentration for further studies. 
It was hypothesised that the cytocompatibility of extracts of composites would be 
affected by the co-initiator used, based on the size of the co-initiator and its ability to 
bind to the polymer, but that the conversion would not vary significantly when the same 
molar was used. As expected, there was no statistical difference in conversion of 
composites containing varying co-initiator at the same molar concentration, i.e. the 
same number of co-initiator molecules per specimen, regardless of the size of the 
molecule. WST-8 activity was elevated in all composite extracts compared to the 
control. Rather than improving cytocompatibility, it is more likely that this indicates a 
response to the co-initiator, though this study is inconclusive regarding whether this is 
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a positive or negative response. Future research should focus on better determining 
the cytocompatibility of composites containing different co-initiator types and 
concentrations. This should be done using multiple cytocompatibility assays, for the 
reasons discussed in Chapter 5, as well as studies on genotoxicity. 
In theory, Na-NTG-GMA should be the most cytocompatible of the co-initiators tested, 
since it has the largest Mr and contains a methacrylate group, through which it can 
easily become incorporated into the polymer. It also has the potential to improve 
bonding to tooth mineral via Ca. Due to the inconclusiveness of this study, however, 
DMAEMA, which also contains a methacrylate group, was selected for continued use 
in Chapter 7, since it is more widely used as a co-initiator and the WST-8 activity of 
cells exposed to DMAEMA-containing composite extracts closer matched that of the 
control. 
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7 EFFECTS OF CALCIUM PHOSPHATES AND ANTIMICROBIAL 
AGENTS ON MINERAL FORMATION AND MATERIAL 
PROPERTIES 
Note: Chapter 7 is the subject of the following publication and patent application (Refs. 
104,113): 
Walters NJ, Liaqat S, Palmer G, Panpisut P, Mordan NJ, Ashley PF, Young AM. Rapid 
hydroxyapatite precipitation on dental composite surfaces. Under preparation for 
submission to J Dent Res 2016. 
UCL Business. GB Patent Application No. 1313898.7. Aug 2013. 
7.1 Introduction 
Although favoured by clinicians for their excellent aesthetics and strength, the longevity 
of composites is affected by their ~2–6 vol% polymerisation shrinkage138. This is only 
partially compensated by ~1 vol% water sorption. Shrinkage exerts pressure on the 
remaining tissue, which can cause debonding of the restoration. This may be followed 
by the development of interfacial gaps between tooth and restoration which are 
susceptible to microbial microleakage. Acidic microbial waste products further expedite 
the demineralisation of the tooth. These factors can ultimately result in recurrent caries 
and failure of the restoration139. 
The aim of the present Chapter was to produce remineralising, antimicrobial 
composites to overcome these issues. The objectives in such materials are for CaPs to 
be released and precipitate between the tooth and restoration, minimising 
microleakage and enhancing the restoration interface, combined with antimicrobial 
protection. CaP release encourages greater water sorption, which may be regulated to 
create a tighter interface68. Use of hydrophilic components should then further enhance 
this interface and may even improve initial bonding strength. 
Mobile antimicrobials such as CHXA19,68 and silver nanoparticles81 and immobile 
quaternary ammonium monomers89 have been previously combined with CaPs in 
dental materials. In composites containing MCP, TCP and CHXA, TCP enhanced 
strength by preventing bulk loss of highly soluble MCP and enhancing CHXA release19. 
The present Chapter assessed whether εPL aids CaP release and HA precipitation 
and aimed to determine the individual and combined effects of MCP, TCP and εPL on 
composites stored in SBF, AS and dH2O. SBF was used to simulate super-saturated 
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dentinal fluid, which is secreted by odontoblasts to remineralise dentinal tubules in 
response to caries140. The bio-inspired dental composites under development aim to 
mimic the natural remineralisation process that occurs in the dentinal tubulues and 
protect against microleakage in a similar manner at the tissue-restoration interface. 
Composites were stored in AS in order to prove that mineral formation would not occur 
on the aesthetic, exposed surface. 
A liquid phase based on that developed in Chapter 5101 was combined with MCP 
and/or TCP and/or εPL. The low viscosity and high hydrophilicity of the resulting 
composites were hypothesised to improve dentine bonding. It was also hypothesised 
that, due to its high solubility, εPL would expedite CaP diffusion and precipitation, 
enhancing HA nucleation, and that highly soluble MCP may be sufficient to induce 
mineral formation without requiring poorly soluble TCP, which detrimentally affects 
conversion and strength68. The combined effects of MCP and εPL could therefore 
prevent debonding, microleakage and restoration failure. 
Materials were characterised in terms of conversion and initial τ to human dentine. 
Mass and volume change in SBF and dH2O were quantified by gravimetric analysis 
over one week, the time period during which precipitates visibly formed, and composite 
surfaces analysed after one week using SEM, EDX and Raman spectroscopy. Since 
strength of remineralising composites typically declines upon immersion in liquid for up 
to one month due to component dissolution68, BFS and modulus E were determined 
after 28 days storage in SBF or AS. 
7.2 Formulations 
Composites were prepared using a liquid phase with a fixed formulation, prepared 
according to Chapter 3.1.1.1. This was based on liquid phase UP (Chapter 5, Ref. 101), 
except that the proportion of UDMA:PPGDMA was altered from 3.5:1 molar ratio 
(75.55:24.45 by weight) to 75:25 by weight. The PLR was also altered to 80:20 by 
weight. Six composites with varying filler phase formulations were analysed. The filler 
phases consisted of: OX-50 and GP0.7 fixed at 10 and 30 wt%, respectively, along with 
0 or 20 wt% MCPM, 0 or 20 wt% β-TCP and 0 or 10 wt% εPL. The remainder of each 
filler (10–30 wt%) phase consisted of GP7. Pastes were prepared according to Chapter 
3.1.1.2 and disc specimens produced according to Chapter 3.1.1.3 were used for 
studies, except where otherwise indicated in specific method subsections. Composites 
were designated abbreviations according to the quantity of reactive fillers and are 
summarised in Table 7.1. Note that 10 or 20 wt% in filler phase corresponds to 8 or 16 
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wt% in the composite as a whole, as reflected in the abbreviations. This ratio of filler 
particle sizes was selected for its optimal handling properties and wettability. Filtek 
Z250 was used for comparison. 
Table 7.1. Chapter 7 experimental formulations. 
 
Variable filler phase parameters 
Formulation Mass of reactive filler in composite (wt%) MCP TCP εPL 
M0T0ε0 - - - 
M16T16ε0 16 16 - 
M0T0ε8 - - 8 
M0T16ε8 - 16 8 
M16T0ε8 16 - 8 
M16T16ε8 16 16 8 
 
Fixed filler phase parameters 
GP0.7 30 wt% of filler phase 
GP7 20–60 wt% of filler phase 
OX-50 10 wt% of filler phase 
PLR  80:20 wt% 
 
Fixed liquid phase parameters 
UDMA:PPGDMA 
ratio 75:25 w/w 
CQ 40 mM 
DMAEMA 60 mM 
BHT 100 ppm 
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7.3 Results 
7.3.1 Conversion 
All experimental composites had similar conversion (70.9 ± 1.6%) at 1 mm depth 
(Figure 7.1), ~40% higher than Z250 (50.4%). Conversion of M0T16ε8 was lower than 
that of the other experimental formulations. 
 
Figure 7.1. Conversion of composites containing varying levels of reactive fillers. 
Conversion of composites containing MCP (0 or 16 wt%), TCP (0 or 16 wt%) and εPL (0 or 8 
wt%), with Filtek Z250 as a control. Crosses represent mean, boxes represent 25–75 
percentiles, error bars represent SD. 
7.3.2 Shear bond strength τ (Figure 7.2) of composites to etched dentine without bonding agent followed complex 
trends. All reactive components caused decrease in τ, most significantly TCP. 
Increasing reactive filler content caused only slight reductions in handling properties, 
but TCP did not seem to affect this differently from MCP. Z250 had one of the poorest 
bonds (1.6 MPa), whereas experimental control M0T0ε0 was strongest. 
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Figure 7.2. τ of composites applied directly to human dentine. τ of composites containing MCP (0 or 16 wt%), TCP (0 or 16 wt%) and εPL (0 or 8 wt%), with 
Filtek Z250 as a control. Crosses represent mean, boxes represent 25–75 percentiles, error 
bars represent SD. 
7.3.3 Mass and volume change 
Mass and volume of all experimental formulations increased over one week in dH2O or 
SBF (Figure 7.3a–d), with an initial burst increase within day one. Volume 
measurements had higher SD due to methodological limitations. M0T0ε0 had low final 
mass or volume increase in both media (~0.5–0.8%). M16T16ε0 increased 1.5 and 4.2 
wt% and 2.9 and 5.9 vol% in dH2O and SBF. M0T0ε8 increased 3.6–3.9 wt% but only 
1.3–1.7 vol%. M16T0ε8 increased 4.2 wt% and 2.9 vol% in dH2O, compared to 6.7 and 
5.9 vol% in SBF. M0T16ε8 increased ~4.8 wt% and 2.2 vol%, with little difference 
between media. M16T16ε8 had the highest increases in both media, at 6.2–6.5% in 
dH2O and 8.9–9.3% in SBF. Figure 7.3e–f notably shows that mass and volume 
increase of M16T16ε0, M16T0ε8 and M16T16ε8 but not the other formulations was greater 
in SBF than dH2O. These ‘difference’ values increased in a linear fashion until ~4 days 
(M16T16ε0 and M16T16ε8) or beyond (M16T0ε8). 
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Figure 7.3. Mass and volume change of composites containing reactive fillers. 
Increase in (a, c) mass (wt%) and (b, d) volume (vol%) of composites containing MCP (0 or 16 
wt%), TCP (0 or 16 wt%) and εPL (0 or 8 wt%) over 7 days storage in (a, b) dH2O or (c, d) SBF. 
Errors bars (a–d) represent SD. 
7.3.4 SEM 
Figure 7.4 shows composite surfaces imaged by SEM after one week in SBF. No 
precipitates were observed on M0T0ε0 (a–b) or M0T0ε8 (h). Presence of εPL in M0T0ε8 
caused greater pitting. Precipitates were observed on M0T16ε8 (c–d), but visibility of pits 
indicated lack of a complete layer. In contrast, M16T0ε8 (i–l) was fully covered in 
conjoined, ~3–8 µm diameter spherical crystals resembling HA (j–l), with a new layer 
forming on top. Cracks in the layer developed during specimen dehydration (j–k) and 
under exposure to electrons during microscopy (i). A similar, thinner layer formed on 
M16T16ε0 (e–g). Cracks appeared to have propagated from pits (f). M16T16ε8 (m–p) had 
significant CaP precipitate, though most crystals had smaller morphology, did not cover 
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the entire surface and pitting was more prominent. Around and particularly within 
pores, HA-like morphology was more apparent. 
 
Figure 7.4. Scanning electron micrographs of composites after storage in SBF for 7 days. 
No CaP precipitation was observed on M0T0ε0 (a, b) or M0T0ε8 (h), though the latter had greater 
pitting. A thin layer of precipitate was observed on M0T16ε8 (c, d), with pits still visible. M16T0ε8 
(i–l), by contrast, was covered with a continuous layer of merged spherulites of crystals which 
appeared likely to be HA, with a novel layer forming on top. M16T16ε8 (m–p) had a similar HA-like 
layer, though it did not cover the entire surface and appeared thinner, due to the presence of 
pits. M16T16ε8 (m–p) was only partially covered with a thin layer of precipitate similar to that 
observed on M0T16ε8, with pores filled and surrounded by HA-like crystals.  
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7.3.5 EDX 
Molar Si:Ca:P ratios obtained by EDX indicated presence of HA on M16T16ε0 and 
M16T16ε8 surfaces: 0.19± 0.04:1.70±0.04:1±0.05 (M16T16ε8); 0.01±0.01:1.71±0.01:1±0.02 (M16T16ε0). 
EDX can detect some elements from several microns below the surface, but Si was 
almost completely absent from the surface of these specimens, indicating the presence 
of a relatively thick mineral layer. The Ca:P ratio very closely matches that expected for 
HA, based on the 5:3 (1.67) ratio of ions in HA (Ca5(PO4)3). 
7.3.6 Raman spectroscopy 
Average Raman spectra of composite components, possible precipitates and 
composite surfaces after storage in SBF for one week are presented in Figure 7.5. All 
composites had distinct glass (1370, 1400 cm-1) and polymer (874, 1448 cm-1) peaks. 
These were, however, present to a lesser extent with CaP-containing composites than 
with M0T0ε0 and M0T0ε8. M16T16ε0 and M16T0ε8 had sharp HA peaks (959 cm-1). M0T16ε8 
had a strong β-TCP double peak (947, 968 cm-1). M16T16ε8, by contrast, had a less 
prominent triple peak, indicating presence of both β-TCP and HA. Although εPL had a 
sharp (1442 cm-1) and two very broad (~1010–1190, ~1235–1375 cm-1) peaks, with 
composite surfaces these were below the detectable range.  
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Figure 7.5. Raman spectra of composite components and surfaces after storage in SBF. 
(a) Pure composite components, possible CaP precipitates (glass, polymerised liquid phase, 
εPL, MCPM, β-TCP, DCPA, DCPD and HA) and (b) composite surfaces after 1 week’s storage 
in SBF. The glass filler and polymerised liquid phase were visible in all spectra but gave 
significantly more prominent peaks in M0T0ε0 than with CaP-containing composites. Sharp HA 
peaks were visible on the surfaces of M16T16ε0 and M16T0ε8, whereas M0T16ε8 had β-TCP peaks. 
M16T16ε8 had a mixture of HA and β-TCP on the surface.  
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7.3.7 Mechanical properties 
BFS values were typically higher in AS than SBF, though this was not significant 
except in the case of M16T16ε0 (p < 0.001). BFS (Figure 7.6a) was highest for Z250 
(195, 183 MPa in AS, SBF), followed by experimental control M0T0ε0 (173, 160 MPa). 
Addition of both CaPs without εPL caused no significant decline in BFS of M16T16ε0 
(167 MPa) compared to M0T0ε0 in AS, but a significant decrease to 135 MPa in SBF. 
Three of the four composites containing εPL had significantly lower BFS than those 
lacking it after storage in both media. Values ranged from 67–86 MPa for M0T0ε8, 
M0T16ε8 and M16T16ε8, with slightly higher values for those stored in AS than SBF. 
M16T0ε8, however, had BFS of 134 and 102 kPa in AS and SBF, respectively. While 
these values were lower than those of εPL-free composites, they were significantly 
higher than those of composites containing both TCP and εPL. 
The average E (Figure 7.6b) of experimental formulations stored in AS and SBF 
increased in a similar order to BFS and ranged from ~2.8 GPa for composites 
containing εPL alone or together with TCP (M0T0ε8, M0T16ε8, M16T16ε8) to ~5.7 GPa for 
composites lacking εPL (M0T0ε0, M16T16ε0). In contrast to BFS, however, E values were 
slightly higher in SBF than AS, though this was not significant except in the cases of 
M16T0ε8 (p < 0.001) and M16T16ε8, (p < 0.005). Similarly to its BFS, the average E of 
M16T0ε8 fell between these groups at 4.9 GPa, close to that of Z250 (5.9 GPa).  
 124 
 
 
 
Figure 7.6. Mechanical properties of composites containing reactive fillers. 
(a) BFS and (b) E of composites containing MCP (0 or 16 wt%), TCP (0 or 16 wt%) and εPL (0 
or 8 wt%), with Filtek Z250 as a control after 28 days storage in AS (dark grey) or SBF (pale 
grey). Crosses represent mean, boxes represent 25–75 percentiles, error bars represent SD. 
M16T16ε0 did not have normal distribution according to the Anderson-Darling test but had 
normal distribution according to others (Kolmogorov-Smirnov and Lilliefors tests).  
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7.4 Discussion 
While previously developed composites containing MCP, TCP and chlorhexidine show 
great promise for more conservative treatment of dental caries19, the individual effects 
of each CaP on strength, mass and volume change and HA precipitation had not yet 
been fully elucidated. Furthermore, use of broad spectrum antimicrobial εPL in dental 
composites has not been reported in the literature. It was hypothesised that εPL’s high 
solubility would encourage water sorption, thereby expediting MCP release and HA 
precipitation, and enabling omission of TCP. Although its minimum inhibitory 
concentration is higher (1–20 µg/mL)92,141 than that of chlorhexidine (0.6–4.9 µg/mL)142, 
εPL release can exceed that of chlorhexidine by over an order of magnitude113. 
Furthermore, εPL is more biocompatible than CHXA and can safely be used at high 
doses. 
Conversion at 1 mm depth was unaffected by presence of MCP and εPL, but was 
slightly reduced in M0T16ε8. Although perceived handling properties of pastes did not 
vary noticeably, τ appeared to be associated with the hydrophilicity/hydrophobicity of 
the reactive fillers. MCP, εPL and particularly TCP each caused reduction in τ, though 
that of M16T0ε8 was relatively high (2.2-fold compared to Z250). 
Due to their high solubility, MCP and particularly εPL increased water sorption. This 
should aid CaP diffusion to the tissue-restoration interface. Greater mass than volume 
increase of M0T0ε8 and M0T16ε8 was due to water filling pores created upon εPL 
release. In contrast, greater volume than mass change of M16T0ε8 and particularly 
M16T16ε0 was caused by polymer expansion, caused by greater volumes of water filling 
voids left upon CaP release, combined with novel mineral formation, which resulted in 
thicker but less dense specimens. More rapid mass increases of M16T0ε8 than M16T16ε0 
was due to greater solubility of εPL than TCP. 
SEM, EDX and Raman demonstrated that storage of M16T16ε0 and M16T0ε8 in SBF 
caused rapid and substantial HA formation. Lack of MCP or TCP in Raman spectra 
implied that deposited layers were sufficiently thick to obscure detection of residual 
MCP or TCP. This was in contrast to M16T16ε8, which appeared via SEM to only form a 
thin mineral layer, with HA-like morphology observed only around pores. This suggests 
that MCP is required for HA formation, that TCP is unable to transform to HA without 
MCP being present, due to its poor solubility, and that TCP and εPL each increase and 
expedite CaP release and subsequent precipitation. The lower degree of HA formation 
on M16T16ε8 implied that too great a presence of soluble components (40 wt%) does not 
optimally foster HA transformation. One possible explanation is that too rapid release 
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of CaPs resulted in sudden over-saturation of SBF and precipitation within the solution, 
before nucleation on the composite could occur. 
BFS of composites containing MCP with either TCP or εPL were weakened to a much 
lesser degree than those containing TCP and/or εPL without MCP, likely due to 
mineral formation within the composite. This may have been DCPA, as previously 
observed68, or another CaP phase such as HA, and would require further investigation. 
HA-forming composites (M16T16ε0, M16T0ε8) had slightly higher BFS values after 
storage in AS than SBF, an artefact of the mechanical testing method. The added 
thickness of the specimens accounted for by newly formed mineral, which itself was 
likely porous and brittle, lead to artificial decreases in BFS values in SBF, due to the 
high sensitivity of the equation to specimen thickness (1 mm ± 10%). Composites 
containing MCP with εPL (M16T0ε8, M16T16ε8) had significantly higher E values after 
storage in SBF than AS, likely due to greater ion diffusion from highly saturated SBF 
into these formulations, resulting from greater release of these soluble components 
from the composites. 
In summary, the present research has demonstrated the effectiveness of composites 
containing MCP with either TCP or εPL at forming HA deposits on composite surfaces. 
Of these two formulations, M16T16ε0 absorbed less water and was therefore stronger, 
whereas M16T0ε8 absorbed water more rapidly and therefore likely formed HA faster. It 
also had significantly higher τ, retained good mechanical properties in the range of 
some non-reactive commercial composites and had the extra advantage of containing 
antimicrobial agent εPL. Although further research into the antimicrobial effectiveness 
of εPL-containing composites is required, this study has demonstrated εPL’s ability to 
induce rapid remineralisation. These findings also demonstrate that TCP is not 
required for HA transformation and that more soluble MCP is efficient at nucleating and 
converting to stable HA in the presence of εPL. Rapid formation of stable HA mineral 
within one week would likely improve the tooth-restoration interface, compensate for 
polymerisation shrinkage and protect against microbial microleakage. Furthermore, the 
antimicrobial action of εPL has the potential to protect against post-operative 
contamination, as well as subsequent microleakage and recurrent caries. This may 
allow more conservative and less painful treatment of dental caries by enabling 
restoration of teeth in which only infected (and not affected) dentine has been removed 
and would likely result in increased restoration durability. 
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8 CONCLUSIONS & FUTURE OUTLOOKS 
Chapter 8 aims to concisely summarise the key findings of this thesis. 
In Chapters 1 and 2, teeth, caries and restorative materials were introduced, with a 
focus on how innovative variants are being developed to overcome some of the 
drawbacks associated with composites. Chapter 3 detailed the materials and methods 
used throughout this set of studies, with the specific formulations described under each 
subsequent chapter. 
Chapter 4 is a collection of a variety of preliminary studies which aimed to optimise the 
composite formulations prior to more detailed investigation in the following chapters. 
Chapters 5, 6 and 7 then go on to address the major aims of the project. The key 
observations are summarised below. 
It can be concluded that UDMA significantly improved the conversion, BFS and depth 
of cure of composites compared to Bis-GMA, due to its greater flexibility and lower Tg. 
Its higher conversion also slightly improved cytocompatibility, likely due to reduced 
leaching of monomers. PPGDMA improved conversion relative to TEGDMA. The use 
of UDMA and PPGDMA in place of Bis-GMA and TEGDMA did not cause a detrimental 
increase in polymerisation shrinkage. Although the resazurin assay suggested that 
PPGDMA be more cytocompatible than TEGDMA, WST-8 and MTS assays proved 
inconclusive. Longer-term cytocompatibility and genocompatibility testing is therefore 
required. Furthermore, MTS significantly over-estimated metabolic activity, which 
emphasised the need to perform multiple types of analysis regarding biocompatibility. 
These results suggest that careful consideration should be given to the polymerisation 
behaviour of the monomers used in dental composites, as well as their 
cytocompatibility. This is particularly true in the case of bulk fill materials, which aim to 
expedite the treatment of carious lesions by reducing the number of composite layers 
required, since the effect of monomer on conversion of the present composites was 
more pronounced at 4 mm than at 1 mm. Furthermore, the cytocompatibility test, which 
demonstrated that all formulations affect metabolic activity to different degrees, utilised 
specimens from the bottom 1 mm from a 4 mm stack. The deepest section of a 
restoration receives the lowest intensity of light during curing and as a result, can suffer 
from poor conversion if the constituent monomers lack flexibility. Given that this is also 
the most likely region of the composite to be in close proximity to pulp tissue, 
cytocompatibility is of particular importance for bulk fill materials. 
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The present research has also demonstrated the effectiveness of MCP at forming HA 
deposits on dental composite surfaces. TCP alone did not result in significant mineral 
formation, but when incorporated with MCP, it aided formation of substantial HA 
deposits. Similarly, εPL induced HA formation in MCP-containing composites. 
Incorporation of both TCP and εPL together with MCP resulted in reduced HA 
formation compared to when only one of these components was combined with MCP. 
The rapid formation of a stable HA surface layer within a one week period would likely 
improve the tooth-restoration interface, compensate for polymerisation shrinkage and 
protect against microbial microleakage. Furthermore, the antimicrobial action of εPL 
has the potential to protect against post-operative contamination, as well as 
subsequent microleakage and recurrent caries. 
Overall, this project has been successful in improving the conversion, BFS and 
cytocompatibility of composites without detrimentally affecting shrinkage or depth of 
cure. Furthermore, composites which induced rapid and substantial surface HA 
formation were successfully developed. The water sorption and HA formation of these 
materials should help to improve the tissue-restoration interface and the presence of 
εPL should protect against microleakage. Such materials could be applied without 
requiring removal of affected dentine, allowing for the preservation of more healthy 
tissue and reducing the pain involved. This could be of particular benefit for paediatric 
patients in particular, given the high rate of caries in children5, as well as those more 
sensitive to pain, as well as for patients in developing countries where access to 
equipment such as dental drills is limited. Given that the reactive fillers incorporated 
into these composites do not vary significantly in expense from standard glass fillers 
and that the failure rate of remineralisation and antimicrobial composites may be 
reduced compared to standard composites, this may result in a cost benefit, although 
this cannot be confirmed until long-term post-clinical evaluations can be conducted in 
order to determine the failure rate. 
The major focus of future work should concern the antimicrobial effectiveness of these 
εPL-containing composites. Work has already begun on elucidating the effect of εPL 
against (confidential PhD thesis of Dr. Muhammad Adnan Khan). This will determine 
whether all of the εPL that is released from the composite exists in an active form. 
Additional future work will focus on further optimising the formulations to ensure an 
optimal balance between antimicrobial potential, mineral formation and mechanical 
properties. Studies on the wear resistance and aesthetics of the composites over time, 
as well as the shelf life of composite pastes is also required as the product is 
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commercialised and brought to the clinic. Finally, similar materials utilising a thermal 
initiator system are under development for orthopaedic treatments. Potential 
applications include vertebroplasty, for treatment of vertebral compression fracture, as 
well as maxillofacial surgery. The incorporation of strontium phosphate, growth factors 
such as bone morphogenetic protein 2, bisphosphonates or other therapeutic 
molecules may help to induce more complete integration between the orthopaedic 
composite and the surrounding bone tissue. 
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